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Abstract
Over the last decade, American hospitals have adopted electronic health records
(EHRs) widely. In the next decade, incorporating EHRs with clinical decision sup-
port (CDS) together into the process of medicine has the potential to change the
way medicine has been practiced and advance the quality of patient care. It is a
unique opportunity for machine learning (ML), with its ability to process massive
datasets beyond the scope of human capability, to provide new clinical insights that
aid physicians in planning and delivering care, ultimately leading to better outcomes,
lower costs of care, and increased patient satisfaction. However, applying ML-based
CDS has to face steep system and application challenges. No open platform is there
to support ML and domain experts to develop, deploy, and monitor ML-based CDS;
and no end-to-end solution is available for machine learning algorithms to consume
heterogenous EHRs and deliver CDS in real-time. Build ML-based CDS from scratch
can be expensive and time-consuming.
In this dissertation, CDS-Stack, an open cloud-based platform, is introduced to
help ML practitioners to deploy ML-based CDS into healthcare practice. The CDS-
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Stack integrates various components into the infrastructure for the development,
deployment, and monitoring of the ML-based CDS. It provides an ETL engine to
transform heterogenous EHRs, either historical or online, into a common data model
(CDM) in parallel so that ML algorithms can directly consume health data for train-
ing or prediction. It introduces both pull and push-based online CDS pipelines to
deliver CDS in real-time. The CDS-Stack has been adopted by Johns Hopkins Med-
ical Institute (JHMI) to deliver a sepsis early warning score since November 2017
and begins to show promising results. Furthermore, we believe CDS-Stack can be
extended to outpatients too. A case study of outpatient CDS has been conducted
which utilizes smartphones and machine learning to quantify the severity of Parkinson
disease. In this study, a mobile Parkinson disease severity score (mPDS) is generated
using a novel machine learning approach. The results show it can detect response to
dopaminergic therapy, correlate strongly with traditional rating scales, and capture
intraday symptom fluctuation.
Primary Reader: Dr. Andreas Terzis
Secondary Readers: Dr. Suchi Saria, Dr. Yanif Ahmad, and Dr. David N. Hager
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“Human beings, in all lines of work, make errors. Errors can be prevented
by designing systems that make it hard for people to do the wrong thing and
easy for people to do the right thing.”
– Kohn et al., To Err Is Human: Building a Safer Health System1
Less than a decade ago, nine out of ten doctors in the U.S. updated their pa-
tients’ records by hand and stored them in color-coded files. By the end of 2017,
approximately 90% of office-based physicians nationwide would be using electronic
health records (EHRs).2 The potential benefits of EHRs over traditional paper are
many, including cost containment, reductions in errors, and improved compliance by
utilizing real-time data. The highest functional level of the EHR is clinical decision
support (CDS) and process automation, which are expected to enhance patient health
and healthcare. 3 Therefore, in the next decade, incorporating EHRs with clinical
1
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decision support together into the process of medicine has the potential to change the
way medicine has been practiced and advance the quality of patient care.4
1.1 Machine Learning-based Clinical De-
cision Support System
Figure 1.1: Clinical Decision Support System (CDSS).
A clinical decision support system (CDSS), as shown in Fig. 1.1, is a system
to request the patients’ data and in response, proposes a set of appropriate clinical
decision support, e.g., diagnoses and treatments. The doctor then takes the output
and determines which diagnoses might be relevant and which are not, and if necessary
orders further clinical tests to narrow down the diagnosis or confirm the diagnosis
with treatment orders. To Err is Human, CDSS has been a key element of systems’
approaches to improving patient safety and the quality of care and has been an
2
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essential requirement for “meaningful use” of EHRs.4
A CDSS can be either knowledge-based or non-knowledge-based. Knowledge-
based CDSSs contain the predefined rules (e.g., health-related criteria, standards,
and guidelines) and associate with patients’ data to make the diagnosis. For example,
clinically, the Systemic Inflammatory Response Syndrome (SIRS) is identified by two
or more symptoms including fever or hypothermia, tachycardia, tachypnoea and,
change in blood leucocyte count. This criterion can be easily defined in computer
systems (See Table 1.1). However, not all disease diagnosis can be defined as simple
and perfect rules. For example, acute kidney injury (AKI) is currently detected by
applying a formula (called the AKI algorithm5) to NHS patients’ blood tests, and
severe sepsis and septic shock are diagnosed by using complex inclusion criteria (e.g.,
Press Ganey’s sepsis workflow) in JHMI. These algorithms are good but not perfect:
they have a tendency to generate false positives for patients and insensitive to personal
clinical information, e.g., patients’ age, gender, medical histories, and so on, — all of
which makes a difference.
SIRS Definition
Temp > 38◦C (100.4◦F) or < 36◦C (96.8◦F)
Heart rate > 90
Respiratory rate > 20 or PaCO2 < 32 mm Hg
WBC > 12,000/mm3, < 4,000/mm3, or > 10% bands
Table 1.1: The SIRS criteria (≥ 2 meet SIRS definitions).
Non-knowledge-based CDSSs use a form of artificial intelligence called machine
learning (ML). Machine learning allows computers to learn from past experiences and
3
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find patterns in clinical data. Compared with Knowledge-based CDSS, this eliminates
the need for writing rules and expert input. Also, the complexity of some diseases,
especially for those with an unclear standard for diagnosis in clinical care (e.g., sepsis,
rheumatoid arthritis),6 provides a unique opportunity for machine learning to provide
new insights and has stimulated research into novel methods for this purpose. For
example, researchers from Johns Hopkins University have shown supervised learning
can improve the diagnostic accuracy of sepsis.7–9 Google has developed a machine
learning algorithm to help identify cancerous tumors on mammograms.10 Machine
learning also can help on diagnosis and daily disease management for neurodegen-
erative diseases like Parkinson’s or Alzheimer’s disease.11,12 It’s clear that machine
learning puts another arrow in the quiver of clinical decision making.
1.2 Challenges to Apply ML-based CDS
in Practice
It is still rare for hospitals to adopt machine learning into their healthcare practice,
even though recently, more and more promising research studies have been published
in using machine learning in healthcare, from diagnosis to prognosis, from inpatients
to outpatients, almost covered every corner of healthcare. The ML-based CDS, as
an interdisciplinary practice, has to face several steep challenges, across computer
systems, machine learning, human-computer interaction, health informatics, patient
4
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safety and quality, ethics, etc. In this dissertation, we address the two fundamental
challenges — system and application challenges — in building ML-based CDSS from
a computer system perspective.
1.2.1 System challenges
Infrastructure and tooling. Are we ready to deploy a machine learning model
published in top journals in machine learning and clinical care? The answer is “NO”.
It may be surprising to the academic community that the “core” of what academic
researchers think of as machine learning — training or prediction — is a compar-
atively small, albeit critical, part of the overall decision-generation lifecycle. The
necessary surrounding infrastructure is vast and complex to support end-to-end ap-
plications.13,14 The infrastructure needs to support the end-to-end data pipelines
from extracting EHRs to delivering CDS on the user interface. It should accelerate
the process of turning an idea into an online product and make it configurable and
reusable. It should introduce tools for us to monitor the incoming EHR data flows,
machine learning predictions, CDS outcomes, and user interactions. Also, it should
enable applications to be HIPAA secure and compliant.
Integration of various and heterogenous components. We observe that
a significant challenge in building ML-based CDSS comes from the heterogeneity of
the various components that must be integrated together into production workflows.
A production system must run like clockwork, collecting new EHRs in real-time,
5
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splitting out personalized diagnosis every minute, aggregated reports every hour,
etc. It is challenging to get a bunch of heterogeneous components to operate as a
synchronized and coordinated workflow. Also, since the EHR vendors are both the
original data sources and the CDS destinations (i.e., doctor accesses the CDS from
the EHR vendor), integrating CDSS with a comparatively closed EHR system is not
straightforward.15
1.2.2 Application challenges
Understanding clinical workflows is an iterative process. The clinical
workflows for some diseases, e.g., AKI and sepsis, are complicated for computer scien-
tists to understand and turn them into programmable rules entirely in one go. From
our experience, it is an iterative process to learn from the clinical experts in their
practice. Also, some of the documented workflows have not been precisely adopted
in practice. Those require the system to be adaptive to the iterative learning process
and provides continuous support for your deployment and maintenance.
Prepare EHRs for machine learning is time-consuming. The acquisition,
analysis, interpretation, and presentation of EHR data in a clinically relevant and
usable format is the premier challenge of data analysis in critical care.16 First of all,
the data acquisition can be slowed down due to limited interoperability. In 2017,
there were roughly 1100 vendors that offer an EHR — twice the number of vendors
four years ago.2 Each EHR may provide customized APIs or data schemas for data
6
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access. Even though the on-going standardization of EHR exchange protocols, e.g.,
FHIR (Fast Healthcare Interoperability Resources), may substantially improve EHR
interoperability shortly, the vendor specific APIs are still necessary for the CDSS
to access customized clinical events and hospital-specific clinical workflows. Second,
feature extraction on EHR requires elaborate work. EHR is heterogeneous and intri-
cate. An EHR database (or enterprise data warehouse, EDW) may contain more than
150,000 tables involving more than 140,000 types of medications, 48,000 of lab results,
and 60,000 thousands of timestamped data items. Clinical related data is present in
a plethora of formats including lab results, clinical observations, imaging scans, free
text notes, genome sequences, continuous waveforms and more. However, most ML
systems or algorithms, e.g., Scikit-learn,17 Spark,18 and TensorFlow,19 prefer a data
format called “data frame” (a.k.a. tabular data). It is a data structure representing
samples as rows, each of which consists of many observations or measurements, i.e.,
columns; and the data types of the columns are usually numeric (e.g., integer and
float numbers). The ETL (extract, transform, load) from EHRs to such a data frame
is the first step to fill the data gap between EHR and ML. With a selection of required
measurements from the targeted EHR, machine learning also needs some advanced
features derived from these measurements. The feature engineering framework needs
to maximize reusable code and make it flexible and configurable.
Real-time clinical decision support. Real-time clinical decision support is
vital for some CDS applications to deliver interventions at the earliest time, especially
7
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for some acute diseases, e.g., sepsis. Sepsis starts from the source of infections and
then spread into the blood and other organs rapidly. Without early warning and
intervention, the infection can cause organ dysfunction and even death. Timing is
critical for providing CDS and trigger following with treatments. Real-time CDS may
not be a technical issue for the CDSS integrated with EHR but could be a challenge
if the CDSS is an external application.
Extensibility vs. data dependency. Machine learning models have high data
dependency. No input is even genuinely independent for most machine learning mod-
els, i.e., Changing Anything Changes Everything (CACE). CACE applies not only
to input features, but also to hyper-parameters, learning settings, sampling methods,
convergence thresholds, data selection, and essentially every other possible tweak.13
When deploying an ML algorithm from one site to another, the end-to-end system
needs to be rebuilt and re-evaluated again because the incoming EHRs are changed.
Specifically, features need to be re-extracted and the ML algorithm needs to be re-
trained and verified. Sound system design should minimize the pain in new deploy-




1.3 Contributions of the Dissertation
The contributions of this dissertation are as follows. First, CDS-Stack, an open
cloud-based infrastructure has been provided to catalyze the deployment of machine
learning-based CDS. Specifically, 1) the CDS-Stack provides a full stack, across hard-
ware, service, and interface, to support end-to-end machine learning-based clinical
decision support systems. The stack spans from data acquisition, feature extraction,
machine learning, to CDS integration, security, and monitoring; 2) It provides an ETL
engine to transform heterogenous EHRs, either historical or online, into a common
data model (CDM) in parallel so that ML algorithms can directly consume health
data for training or prediction; 3) It introduces both pull and push-based online CDS
pipelines to deliver CDS in real-time.
Second, we have deployed CDS-Stack at three major hospitals in Johns Hop-
kins Medical Institute (JHMI), and delivered TREWS,7 the targeted real-time early
warning score for sepsis, to Howard County General Hospital (HCGH) since Novem-
ber 2017. The preliminary results showed promising adoption rate by the treatment
team in the pilot study.
Third, CDS-Stack can further extend from in-hospital settings to outpatients. A
case study was conducted for outpatient CDS. In the case study, a mobile Parkinson
disease severity score (mPDS) is generated using a novel machine learning approach.
The score 1) detected response to dopaminergic therapy, 2) correlated strongly with
traditional rating scales, and 3) captured intraday symptom fluctuation.
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1.4 Organization of the Dissertation
The remainder of this thesis is structured as follows. The overview of CDS-Stack
and the preliminary results of TREWS deployment is presented in Chapter 2. The
CDM and ETL engine are presented in Chapter 3. The pull-based and push-based
online ETL pipeline are described in Chapter 4. In Chapter 5, the mPDS, an example
of DDSS at home, is presented. Chapter 6 elaborates related work. Finally, Chapter
7 conclude this dissertation.
1.5 Scope of the Dissertation
The primary goal of this dissertation is not to improve machine learning algo-
rithms, which are almost always “good enough” for many critical applications, but
instead to make them deployable and actionable so that ML practitioners can quickly
apply ML to healthcare practice, achieve high-quality results, and maintain produc-
tion systems in clinical decision support. In this dissertation, we treat the machine
learning algorithms as a black box. Also, the CDS-Stack focuses on using the “main
body” of EHR into CDS, which includes demographics, diagnosis, medical history,
problem list, medication administration, lab results, lab orders, vital signs, etc. And
the current CDS-Stack used the customized API in the targeted EHR, Epic. And we
haven’t covered the implementation with FHIR since it was still under construction
in JHMI. This dissertation does not focus on using specific types of EHRs to imple-
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ment CDS, e.g., medical image-related machine learning-based CDS or the NLP of
medical notes. This dissertation also focuses on diagnostic decision support, one of
the critical categories of CDS. While clinical decision support can be a broader set of
tools, including clinical guidelines, condition-specific order sets, focused patient data
reports and summaries, documentation templates, etc.
11
Chapter 2
Overview of the CDS-Stack:
Architecture and Deployment
“The workman who would do his work well should first sharpen his tools.”
– Confucius, The Analects of Confucius
2.1 Introduction
Despite incredible recent advances in machine learning for healthcare, building
machine learning-based clinical decision support system remains prohibitively time-
consuming and expensive. This expense comes not from a need for new and improved
statistical models but instead from a lack of systems and tools for supporting end-
to-end machine learning application development, from data preparation and feature
12
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extraction to deployment and monitoring. Therefore, we developed CDS-Stack, an
open cloud-based platform for ML practitioners to develop, deploy, and maintain
their ML-based CDSS. Using CDS-Stack, developers do not need to build the end-
to-end ML-based CDSS from scratch; instead, CDS-Stack provides infrastructure
and building blocks for developers to start with. The CDS-Stack is available at
https://github.com/cloud-cds/cds-stack.
Our design philosophy in the CDS-Stack centers around two central tenets:
• Target end-to-end ML-based CDS workflows. ML-powered CDS development
consists of far more than model training. As a result, today, the bulk of chal-
lenges in developing new ML-powered CDS are not in model training but are
instead in data collection/preparation, feature selection/extraction, and deploy-
ment (serving, monitoring, debugging, etc.). Systems should target the entire,
end-to-end workflow so that machine learning can be turned into supportive
and actionable clinical decisions.
• Catalyze the deployment of ML-based CDS. Although machine learning appli-
cations in CDS are impressive, there is lack of systems or tools for machine
learning and domain experts to build those applications. These questions will
repeatedly be asked: How to access, clean, and use the health data for machine
learning development? How to deliver ML-based CDS back to the doctors in
real-time? How to operate, monitor, and debug the ML-based CDS once it is
deployed? Systems should extricate machine learning and domain experts from
13
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those questions and let them focus on domain-specific problems, e.g., model
tuning and improvement.
2.2 Architecture
Figure 2.1: The CDS-Stack provides an end-to-end stack across hardware, service,
and interface layers for the development and deployment of machine learning-based
clinical decision support.
The CDS-Stack provides a full stack, crossing hardware, services, and interfaces,
to deploy an end-to-end machine learning-based clinical decision support system on
the cloud. A huge advantage of building CDS externally on the cloud is that the CDS-
Stack can utilize the latest technology, maximize the scalability and extensibility, and
also contribute to the open source community. In contrast, an internal CDS design can
14
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increase the coupling with a specific EHR vendor and make the system more difficult
to develop, maintain, and enhance. If we also consider the technical backwardness and
isolation of commercial EHR vendors, the design choice of the internal CDS should be
avoided. The CDS-Stack aims to support the end-to-end system spanning from four
main functionalities, which are data acquisition, feature extraction, machine learning,
and CDS.
2.2.1 Hardware layer
The CDS-Stack hardware foundation is based on an infrastructure as a service
(IaaS) model to achieve scalable, flexible, and cost-efficient hardware usage for various
CDS usage cases. With IaaS, developers can direct access to their servers and storage,
just as they would with traditional servers but gain access to a much higher order
of scalability. Users of IaaS can outsource and build a “virtual data center” in the
cloud and have access to many of the same technologies and resource capabilities
of a traditional data center without having to invest in capacity planning or the
physical maintenance and management of it. Compared with other two cloud service
models, i.e., Software as a Service (SaaS) and Platform as a Service (PaaS), IaaS is
the most flexible cloud computing model and allows for automated deployment of
servers, processing power, storage, and networking. IaaS gives CDS-Stack developers
true control over their infrastructure than users of PaaS or SaaS services.
The CDS-Stack provides cloud orchestration tool to manage the interconnections
15
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and interactions among workflows on the cloud infrastructure. The cloud orchestra-
tion tool in CDS-Stack is used to provision, deploy or start services, acquire and assign
storage capacity, manage networking, and gain access to specific software on cloud
services. It enables service, workload and resource orchestration and can integrate
permission checks for security and compliance.
The hardware layer allows developers to allocate all resources and scale them
manually or automatically based on the on-demand usage.
2.2.2 Service layer
When considering scalable system design, it helps to decouple functionality and
think about each part of the system as its own service with a clearly defined interface.
Therefore, the service layer of CDS-Stack defines all the necessary building blocks
(services) for the end-to-end ML-based CDSS.
For example, the database service provides the APIs for the data storage and ac-
cess to both offline datasets (data warehouse) and online data flow (online database).
The offline and online ETL components take in charge of data acquisition and feature
extraction for historical EHR datasets and online EHR data streams respectively. The
raw EHR data will be extracted, cleaned and transformed into a common data model
(CDM) and saved into the database. The ML development and prediction compo-
nents are the core of ML. CDS-Stack does not specify which kind of ML framework
to use; the developers can integrate their favorite ML tool as a container in CDS-
16
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Stack, e.g., using R, Python scikit-learn, Spark, or TensorFlow. And the AlertServer
and WebService are the two major components to generate and deliver CDS. The
AlertServer coordinates the CDS generation when new ETL is done. It triggers the
predictor to predict on updated patients and then generates the CDS content and
alerts. The main contents of CDS are served as web pages in the WebService. Those
web-based contents can be seamlessly embedded into the EHR system to server the
treatment team. The WebService uses a typical memory cache to minimize the la-
tency of requests and can scale up and down based on the service load. Once the new
contents and alerts are ready, the AlertServer notifies the WebService to invalidate
and refresh the cache and then push the new alerts to the targeted EHR system.
Besides, monitoring and auditing services take the system and user behavior under
supervision. Developers can define either system or application metrics and push to
a central monitor to visualize, set alarms, and automatically react to the changes in
the system.
Creating redundancy in a system can remove single points of failure and provide a
backup or spare functionality if needed in a crisis. To handle failure gracefully, CDS-
Stack enables the redundancy of its services by default. For example, by default, at
least two instances of the WebService is running to serve the CDS. If there is only
one instance of the web service, then losing that instance means the CDSS is out of
service.
17
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2.2.3 Interface layer
On the interfaces layer, the web and alerts are the two types of interfaces to the
doctors. The web interface is cross-platform and accessible on any desktop, laptop, or
smartphone. Its interoperability allows it is easily embedded into the EHR system.
The alert interface is an event-based interface to trigger the treatment team with
alerting messages. Those messages can be pushed to the EHR vendor’s notification
system through its API.
Besides, interfaces for maintenance and monitoring purposes are provided. For
instance, the application level dashboard, alarm, and report are provided for the
system administrators to monitor the running and performance of the end-to-end
application. Developers can establish periodical jobs to generate outcome reports
to either their emails or communication channels; they can also add new metrics
and visualize them in the dashboard to monitor some key numbers, e.g., current
positive cases, number of infected inpatients, etc. System-related dashboard and
alarm are used to monitor system performance and debugging. Traditional cloud
system monitoring is provided, e.g., monitoring of CPU, memory, IO usages of each
instance and group. Some critical service metrics are implemented too, e.g., the
duration of ELT, prediction, etc. The developers can customize those metrics and
dashboards.
18
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2.3 Implementation
Figure 2.2: The implementation of CDS-Stack on AWS. The black lines stand for
the data flows and the blue lines represent the control flows for the developers.
Fig. 2.2 draws the implementation of the CDS-Stack on Amazon Web Services
(AWS) and presents the data and control flows in detail. We elaborate five critical
components implemented in CDS-Stack as follow, which are cloud infrastructure,
end-to-end data pipelines, CDS integration, monitoring, and security.
19
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2.3.1 Cloud infrastructure
As mentioned in Section 2.2.1, the CDS-Stack is built on top of an infrastructure
as a service (IaaS) model. AWS, as one of the leading IaaS providers, supplies a range
of services to accompany those infrastructure components, including detailed billing,
monitoring, log access, security, load balancing, and clustering, as well as storage
resiliency, such as backup, replication, and recovery. The CDS-Stack is located in an
AWS Virtual Private Cloud (VPC) which is a virtual network dedicated to CDS-Stack
AWS account and logically isolated from other virtual networks in the AWS Cloud.
The IaaS model provides customizable resource usage (e.g., auto scaling groups) and
can “pay as you go” which is much more flexible for the developers comparing with
other cloud computing models, e.g., platform as a service (PaaS) or software as a
service (SaaS). For instance, The WebServer is deployed in an auto-scaling group
which can scale up and down based on the load of the web service. Terraform20 is
used in CDS-Stack to codify the configuration of the infrastructure into declarative
configuration files that can be shared amongst team members, treated as code, edited,
reviewed, and versioned.
Also, cloud orchestration is achieved via Kubernetes21 to manage the resources
and services on the cloud infrastructure. Kubernetes is an open-source system for
automating deployment, scaling, and management of containerized services. In CDS-
Stack, for example, all services are implemented as a Kubernetes’ Pod — the smallest
and simplest unit in the Kubernetes object model that you create or deploy. A
20
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Pod encapsulates an application container (or, in some cases, multiple containers),
storage resources, a unique network IP, and options that govern how the container(s)
should run. It represents a unit of deployment: a single instance of an application
in Kubernetes, which might consist of either a single container or a small number
of containers that are tightly coupled and that share resources. For example, the
WebServer pod is the object to deploy the web service of CDS-Stack. It includes
two containers, a Nginx container, and a Gunicorn container. The Nginx one is
the HTTP server to host the Gunicorn web application, i.e., a Python web service
implemented the CDS application logic. Each pod has a configuration file to define
which containers to include (i.e., the docker images), resource usages (i.e., CPU and
memory), the number of replicas, and the public URL, etc. This abstraction simplifies
and automates the deployment of each service on the CDS-Stack.
2.3.2 End-to-end data pipelines
The end-to-end data pipelines cover both the offline and online data paths from
requesting health data from external data sources, extracting features, to running
machine learning and finally generating clinical decision support. The “pearls” in
this necklace are wrapped as containerized services as well. For example, the data
acquisition and feature extraction process are implemented as an ETL service or
job. In the offline ETL, the original EHR data is extracted from the historical EHR
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database, e.g., Epic Clarity 1, and occasionally or periodically dumped to the AWS
S3 bucket. Then, the ETL instance can be established to transform and load them
from the bucket to the data warehouse using the AWS RDS. The machine learning
development component can be implemented as a containerized service using any
ML libraries, e.g., TensorFlow.19 The training results then can be saved in the data
warehouse.
For online ETL, both the pull and push-based protocols are implemented. The
pull-based protocol periodically creates an ETL job in the ETL auto scaling group by
using the time-based AWS CloudWatch event (similar to a cron job on the cloud). The
ETL job will extract all EHRs for current bedded patients in a hospital, including vital
signs, medications, lab results and procedures, diagnosis and medical history, clinical
notes, etc., and then transform and load the data into the online database using
the same pipeline as the offline ETL. In contrast, the push-based protocol will keep
maintaining live connections between the EHR event dispatcher and the EventProxy
service to make sure all live EHR events will be forward to the event buffer in time.
The event buffer is implemented as a queue in the AWS Simple Queue Service (SQS)
which guarantees all incoming messages will be reliably enqueued and then sent to
the consumer (EventServer) at least once. The EventServer then triggers the ETL
process as same as the pull-based protocol. The significant advantage of the push-
based protocol is that the ETL can run in a timely fashion for only the patients
1The Clarity database is a SQL database for analytics which extracts EHR from the Epic’s
production database Chronicles every night
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who have new measurements. When the ETL is done, whether pull-based or push-
based, the AlertServer will receive the ETL done message from the ETL instance
and then trigger the predictor to run and generate CDS contents and alerts based on
the prediction results. For ML developers, they can focus on building the prediction
service here and decouple the rest of the application logic into other services.
In the offline pipeline, we use different dataset id and model id to represent
different EHR datasets and machine learning models respectively so that developers
can compare and evaluate their approaches on different datasets with various machine
learning algorithms.
In the online pipeline, we enable three environments which are test, stage, and
production. Each of them has their own services, e.g., database and web service.
The test environment is connected to the test environment of the EHR system, and
developers can do unit and integration tests on the test environment, e.g., new fea-
ture extraction and new CDS logic. Both stage and production environments are
connected with the EHR’s production system but only the CDS from the production
environment can be used in the EHR system. Developers can use this stage environ-
ment to run end-to-end performance tests, e.g., test a new model for one week before
launch. An update on the end-to-end system has to pass the tests on the test and
stage environment first, before launching to the production environment.
Chapter 3 elaborates the data schema and ETL design to enable the end-to-end
data pipelines, and Chapter 4 describes the two protocols — pull and push — in
23
CHAPTER 2. THE CDS-STACK OVERVIEW
delivering real-time CDS in detail.
2.3.3 CDS integration
The CDS-Stack attempts to integrate CDS seamlessly into the EHR vendor’s
system. It embeds the CDS into the current clinical workflow and interface, so as to
minimize the changes of the current workflows and the following educational cost.
The two primary CDS interfaces are CDS alerts and web pages. An alert can
be pushed to the right places instantly once a new CDS is produced. For example,
an alert can push to the patient list where the nurses and doctors keep checking
or display as a notification message to the doctor’s phone. The alert service aims
to trigger the treatment team and let them investigate the alert in the web pages.
The web pages provide a user interface with one-stop service, including the detailed
messages to deliver and actions the treatment team can take so that if the physician
acknowledges the alert, they can place additional orders or medications without switch
context.
In sum, the CDS-Stack applies a hybrid integration approach to deliver CDS
back to the EHR vendor’s system: the decision support logic is implemented entirely
external, i.e., in the CDS-Stack cloud, but the decision support interface is embedded
into the EHR vendor’s system. This design choice maximizes the flexibility of CDS-
Stack in implementing the CDS logic and user interface, and meanwhile, minimize
the changes needed for the treatment team to use the CDS in their daily workflow.
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2.3.4 Monitoring
It is dangerous to rely on an unmonitored machine learning model for any decision-
making. As ML models are deployed, they must be monitored and tuned periodically.
Otherwise, ML models may “drift”, in which phenomena evolve, but models do not
can be catastrophic. For example, Google Flu Trends, which used common search
terms as a signal for influenza prevalence, was prominently featured in a 2008 Na-
ture paper, only to later miss the peak of the 2013 flu season by a considerable
margin.22 The monitoring services of CDS-Stack keep collecting metrics, draw dash-
boards, and trigger alarms for developers to manage production services and debug.
The CDS-Stack utilizes AWS CloudWatch and Prometheus23 to collect metrics in
both hardware, service, and interface levels.
Example of dashboards are drawn in Grafana,24 an open platform for data ana-
lytics and monitoring, to display all running status in a central place (see Fig. 2.3).
These dashboards can help developers to keep monitoring the hardware usage for
each service in the cloud; the application can also setup dashboard to track critical
processes, e.g., the data streaming in each ETL. Furthermore, data visualization is
included in CDS-Stack too by using Redash25 to help understand and investigate all
the data in the database (see Fig. 2.4). For example, Fig. 2.4a shows the current
bedded patients grouped by the hospital; Fig. 2.4b summarizes the number of times-
tamped features per hour during the latest 48 hours. Fig. 2.4 is an exciting flowchart
to show how patients move in the hospital. These figures directly query and visualize
25
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(c) CDS dashboard.
Figure 2.3: The hardware and service dashboards in CDS-Stack
the data from the databases and can be a powerful tool for data exploration.
The CDS-Stack alarms are defined using AWS CloudWatch Alarm and configured
to deliver to multiple channels, e.g., developers’ emails and the developers’ channel
on Slack, using Amazon Simple Notification Service (SNS). Fig. 2.5 shows both the
revoked and active alarms have been delivered to the developers’ channel on Slack.
2.3.5 Security
The CDS-Stack architects for HIPAA security and compliance on AWS.26 In high
level, AWS Key Management Service (AWS KMS) is used to manage keys and encrypt
PHI. Specifically, there are two aspects that CDS-Stack provides to enable HIPAA
27
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(a) Encounter visualization. (b) CDM data visualization.
(c) Care unit flow visualization.
Figure 2.4: The CDS-Stack data dashboards.
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Figure 2.5: The alarms have been fired to the developers’ channel on Slack.
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security and compliance. One is to guarantee the Personal Health Information (PHI)
are always encrypted at rest or in transit. The other is to enable auditing, back-ups,
and disaster recovery.
2.3.5.1 Encryption and protection of PHI
The HIPAA Security Rule includes addressable implementation specifications for
the encryption of PHI in transmission (“in transit”) and in storage (“at rest”). Al-
though this is an addressable implementation specification in HIPAA, AWS requires
customers to encrypt PHI stored in or transmitted using HIPAA-eligible services un-
der guidance from the Secretary of Health and Human Services (HHS).
In CDS-Stack, all network traffic containing PHI has been encrypted in tran-
sit. For traffic between external sources (such as the EHR vendor) and CDS-Stack,
industry-standard transport encryption mechanisms such as TLS are used. When the
data is at rest, i.e., in the databases, the data is always encrypted, and the secret is
securely stored.
2.3.5.2 Auditing, back-ups, and disaster recovery
HIPAA’s Security Rule also requires in-depth auditing capabilities, data back-up
procedures, and disaster recovery mechanisms. The services in CDS-Stack contain
many features that help customers address these requirements.
The CDS-Stack puts auditing capabilities in place to allow security analysts to
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examine detailed activity logs or reports to see who had access, IP address entry,
what data was accessed, etc. This data can be tracked, logged, and stored in a central
location (e.g., CloudWatch and CloudTrail) for extended periods of time (e.g., one
month), in case of an audit. Also, CDS-Stack can further back up the log files into
Amazon S3 for long-term reliable storage. Additionally, all CDS contents and alerts
generated in CDS-Stack has been sent to the EHR vendor and stored in the EHR
database for auditing.
Under HIPAA, covered entities must have a contingency plan to protect data
in case of an emergency and must create and maintain retrievable exact copies of
electronic PHI. CDS-Stack implements both data and service backup plan on AWS:
CDS-Stack keeps backing-up RDS databases every day by default. Amazon S3 also
provides a highly available solution for data storage and automated back-ups. By
simply loading a file or image into Amazon S3, multiple redundant copies are auto-
matically created and stored in separate data centers. These files can be accessed at
any time, from anywhere (based on permissions), and are stored until intentionally
deleted. By default, the CDS-Stack launches production instances (Amazon EC2 in-
stances) in multiple Availability Zones to create geographically diverse, fault-tolerant
systems, and most other probable sources of downtime.
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2.4 Preliminary Results
Starting from 2017, we implemented and deployed the TREWS7 alert — a sepsis
early warning score based alert — using the CDS-Stack to replace current CMS
sepsis alert in JHMI. It is the first time that a machine learning-based diagnostic
decision support has been deployed into healthcare practice in a hospital, to the best
of our knowledge. This section shares the preliminary results we learned from this
deployment.
2.4.1 What is sepsis?
Sepsis, a syndrome of physiologic, pathologic, and biochemical abnormalities in-
duced by infection, is the leading cause of death in US hospitals and also a major
public health concern, accounting for more than $20 billion (5.2%) of total US hos-
pital costs in 2011.27 Awareness of sepsis can saves lives. This awareness has led to
efforts to ensure that all sepsis patients are treated quickly, including the Centers for
Medicare and Medicaid Service (CMS) guidelines for Severe Sepsis and Septic Shock
Quality Measures. However, the CMS continues to rely on the Sepsis-2 definition
which results in inadequate sensitivity and specificity of SIRS criteria for identifying
sepsis. Instead, the retrospective analysis indicated that the new Sepsis-3 definition
could be a useful clinical tool. However, because most of the data were extracted
from extracted US databases, the task force strongly encourages prospective valida-
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tion in the multiple US and non-US healthcare settings to confirm its robustness and
potential for incorporation into future iterations of the definitions.28
Based on such reality, researchers started to use machine learning methodology
to detect sepsis and septic shock. TREWS7 is one of the best sepsis early warning
system among all publications. It identified patients before the onset of septic shock
with an area under the ROC (receiver operating characteristic) curve (AUC) of 0.83
[95% confidence interval (CI), 0.81 to 0.85]. At a specificity of 0.67, TREWScore
achieved a sensitivity of 0.85 and identified patients a median of 28.2 [interquartile
range (IQR), 10.6 to 94.2] hours before onset. It can be a powerful alert to replace
current rule-based CMS sepsis guideline.
2.4.2 TREWS deployment
TREWS was initially developed on the MIMIC (Multiparameter Intelligent Mon-
itoring in Intensive Care)–II Clinical Database.29 To build and deploy it into hospi-
tals in JHMI, TREWS has evolved with new ideas30 and re-trained from the JHMI
datasets, specifically, a three-year EHR dataset of Howard County General Hospital
(HCGH) stored in the CDS-Stack data warehouse. The CDS-Stack enables the offline
analysis and the online pipeline to build and deliver TREWS alerts to hospitals in
JHMI. The latest version of TREWS showed it could identify 80% of the sepsis cases
of 0.40 positive predictive values (PPV). In contrast, the current CMS definition only
identified 49% of patients any time prior or within half hour after the onset of sepsis.
33
CHAPTER 2. THE CDS-STACK OVERVIEW
And the PPV of CMS alerts (assuming alerting every time criteria is met) was less
than 0.09.
Using the CDS-Stack, the TREWS alert has been deployed in HCGH since Novem-
ber 2017. From November 2017 to the end of December 2017, 13,416 patient encoun-
ters have been monitored in the background, and 845 patients among all have shown
positive on TREWS alerts. The preliminary results are shown as follow:
• 51.5% of TREWS alerts had a user response.
• 60% of alerts got one page view at least.
• Of alerts with a user action, 59.0% confirmed infection, 41.0% entered no infec-
tion suspected, and 1% used manual override without entering SOI.
The user engagement has been shown to be much better than the previous CMS alerts
which were usually ignored by the treatment team. In this deployment, the CDS-Stack
supported TREWS to 1) maximize feature engineering code in both offline training
and online prediction; 2) keep feeding the TREWS model with online EHR data; and
more importantly, 3) continue monitoring its performance, including accuracy and
user engagement.
2.5 Discussion
The CDS-Stack provides an open-source toolkit to relief the pain of developing
and deploying machine learning-based CDS into clinical practices from scratch. Com-
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pared with other CDSSs31–33 which generally adopted the SaaS model, CDS-Stack
maximizes the flexibility and reusability for ML practitioners to implement new ML-
based CDS and extend it into new medical institutes. The machine learning and
domain experts can focus on feature selection and tuning of the machine learning
algorithms instead of “plumbing”, i.e., integrating various components together into
production. To our best knowledge, CDS-Stack is the first open-source cloud-based
solution that speeds innovation on ML-based CDS.
So far, the CDS-Stack is still the first step to catalyze clinical innovations using
machine learning. It has several limitations. First, the CDS-Stack was implemented
and evaluated only with the leading EHR vendor in US, Epic system, within JHMI
currently. It will be beneficial to extend and try it with other EHR systems and
medical institutes. Second, current clinical outcomes were implemented manually in
CDS-Stack, a library of standard clinical outcome metrics is not available now. Such a
library, including standard clinical metrics like length of stay, mortality, readmission
rate, etc., can be used to evaluate ML-based CDS in the long run and provide a
meaningful clinical datasheet for CDS benchmarking. Third, the web-based CDS
interface only supported one theme or style right now. A system to switch and




CDM: Transforming EHRs to
Common Data Model
3.1 Motivation
“It is a capital mistake to theorize before one has data.”
– Sherlock Holmes, “A Study in Scarlett” (Arthur Conan Doyle).
The premise of using ML in CDS is to be able to convert EHRs into the right data
format for ML usage, e.g., training or prediction. However, EHRs cannot be directly
consumed by machine learning algorithms.
First of all, the generic format of ML dataset, called data frame, is a tabular
dataset with each row as a sample and each column as a specific feature or measure-
ment, while, current EHR data is heterogenous and dispersed on multiple different
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places with various formats. For example, The Epic Clarity database, one of the most
adopted historical EHR database, has thousands of tables and the EHR data like vi-
tal signs, lab results, clinical notes, etc. is stored at different tables with different
attributes. Furthermore, if you want to access online EHRs in real-time, you have
to request the endpoints from the Epic’s interconnect web service using SOAP or
REST APIs, or FHIR web services which is also based on REST APIs. Multiple web
requests are needed and the received data format changes to either JSON or XML.
Second, the success of ML development and deployment rely on high-quality data
and data consistency. However, since current EHRs are not quality guaranteed and
the interoperability is quite low among different sites and EHR vendors, A data
cleaning and preprocessing is essential before severing them to ML algorithms.
Third, even though some EHR vendors start to build EDWs (enterprise data
warehouses) and try to share EHRs in an easy-to-use format, their data schema
is not specific for ML usage. Machine learning scientists or engineers still need to
operate multiple complex queries and calculations to generate a dataset ready for
use, including data cleaning, table join, fill in missing values, feature extraction, and
so on.
To our best knowledge, there is no such a tool specifically designed to convert
EHRs for ML usage. Therefore, we introduce CDM (common data model) — a
simple and generic database schema for machine learning usage. The CDM contains
an entity–attribute–value model (EAV) to represent health data in a simple form and
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a data frame format for machine learning algorithms to use directly. To well abstract
the conversion from EHR to CDM, An ETL engine is designed and implemented to
execute this process. The ETL engine is a modularity framework in order to improve
the maintainability and scalability and maximize the code reusability. CDM unifies
the data format on both the offline and online databases. The benefit is that once
the online CDM data pipeline is developed, the ML models developed from the offline
CDM dataset can be directly deployed into the online environment.
3.2 CDM database schema
CDM is designed as a database schema in relational (SQL) database. We choose
SQL instead of NoSQL because we need a robust store with enforced data integrity
and transaction support. Only an SQL database will (currently) satisfy those require-
ments. The core CDM tables is shown in Fig. 3.1 and described in Table. 3.1. Note
that both the data warehouse and online database of CDS-Stack use the same CDM
schema and the only difference is that the online database has no dw version table
and dataset id column in these tables because the online database only contains a
single data source.
The main design principle of CDM is to keep it simple and easy to adopt:
Only simple query is needed. Compared with the thousands of tables in the
Clarity database, CDM only contains less than ten main tables. All features can be
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Figure 3.1: The core CDM database schema. The cdm s, cdm t, and cdm note
tables represent EHR using the EAV model and the cdm df table is the data frame
to store a complete dataset for ML usage.
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Table Description
dw version The table list all datasets in the data warehouse.
pat enc The main patient table. The enc id (encounter ID) is the internal
id of an inpatient visit. The pat id and visit id stores the original
patient ID and visit ID respectively.
cdm feature The CDM feature dictionary. It list the feature’s category (i.e.,
which CDM table it locates), data type (e.g., Integer, Real,
Boolean, JSON, String), and either raw measured feature or deriva-
tive features. If it is a derivative feature, it list its derive function
and depending features.
cdm s The CDM table stores static feature values, i.e., those keep stable
in an inpatient visit, e.g., age, gender, medical history, etc.
cdm t The table stores timestamped feature values, e.g., vital signs, lab
results, medication administration, etc.
cdm df The data frame table. The primary keys are dataset id, enc id,
and tsp. The rest columns are the measurements to be used in ma-
chine learning. The columns ending with c is the confidence value
of that measurement, which indicates how does the value generated,
e.g., originally load from EHR source, transformed, filled-in.
cdm note The table stores clinical notes.
cdm label The table stores generated labels with version control.
cdm stat The table stores statistical reports of CDM features.
Table 3.1: The description of the core CDM Tables.
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easily located by query the cdm feature table.
Can be directly consumed by ML algorithms. A ML algorithm can directly
load cdm df table to start training or prediction. In addition, a simple join query can
be used to combine some static feature values, e.g., age and gender from cdm s with
cdm df.
Supports various EHR data types. The data type of the value field in cdm s
and cdm t is text which supports flexible data types. Even some complex data type,
e.g., some events with multiple attributes, can be represent as JSON string to store in
this field.
Allows scalable read and write. All the CDM data tables can be partitioned
by dataset id and enc id in either read or write operations. It is highly parallelizable
for reading and writing to those tables.
3.3 ETL: transforming EHR to CDM
How to transform original EHRs into CDM? We describe this process as an ETL
process. ETL is short for extract, transform, and load, which are the three steps
to pull data out of one database and place it into another database. Specifically,
the ETL in CDS-Stack stands for the process of extracting EHR data sources, e.g.,
databases or REST APIs, transforming, and loading into a CDM database.
The concept of the ETL process is drawn in Fig. 3.2. The ETL first extracts the
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Figure 3.2: The ETL data integration from EHR to CDM.
targeted EHRs from either historical EHR databases or online APIs with a feature
mapping configuration. The feature mapping configuration is predefined with specific
queries (e.g., Q1 in Fig. 3.2) to map a particular external EHR to a feature ID (fid
defined in cdm feature). A transform function is specified for each fid to transform
the values (including unit conversion, deleting the dirty or coarse data and data
filtering) and then convert and load to the EAV models, i.e., a record in cdm t,
cdm s, or cdm note.
The last but not least step is to create the data frame in cdm df. This step
includes two sub-steps: fill-in and derive as illustrated in Fig. 3.3. The fill-in
process loads raw measured feature values from cdm t into cdm df and meanwhile fills
in missing values using a fill-in function, e.g., carry on the last value. For example,
Fig. 3.3 imports two raw features spo2 (i.e., SpO2) and hr (i.e., heart rate). Their
measurements have shared timestamps (tsp), but there are timestamps when only
one measurement exists, e.g., the first row and the last row in this case. The fill-in
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Figure 3.3: An example of generating cdm df table using fill-in and derive process
function is to make sure those gaps can be filled in based on some rules. For example,
carry on the last spo2 value 98 into the last value; for those without previous value, a
population mean can be used, e.g., the first heart rate value 83. The confidence values,
e.g., spo2 c and hr c is used to track the source of those values, either originally
measured, unit transformed, or filled-in by last value or population mean.
Once all the missing values are filled in for raw measurements, it’s easier to gen-
erate derivative features based on them. Taking SIRS as an example, mentioned in
Table 1.1, it can be easily calculated if all raw input measurements are ready for
each timestamp. Fig. 3.4 shows all the features needed to generate a derivative fea-
ture called septic shock, including raw measurements (i.e., the leaves without any
inbound arrow) and other derivative features. This dependency graph is a directed
acyclic graph (DAG) which has at least one topological ordering. The topological
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sorting can be used to schedule those derive functions based on their dependencies.
Figure 3.4: An example of dependency graph for septic shock
After the fill-in and derive processes, a complete data frame is generated, which
means all raw and derivative features are generated with no missing value.
3.4 The ETL engine: the framework to
build ETL pipelines
Section 3.3 describes the concept of the ETL process to turn EHR into CDM and
in this section, we introduce the ETL engine to help build such an ETL pipeline and
handle both dependency resolution and parallelism.
The ETL engine is implemented using Asyncio, the asynchronous programming
model introduced after Python 3.4. Asyncio is a library to write asynchronous appli-
cations. It is the most efficient way to implement a network server having to handle
many concurrent users. Here, the ETL engine uses Asyncio to handle concurrent IO
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tasks, which are heavy on the database queries and HTTP requests. Even though
it won’t improve latency since await-ed functions still have to wait for IO, while the
await-ed functions wait for IO, control is automatically returned to the event loop
so other code can run. In contrast, serially making those requests and waiting for
responses would be painfully slow. Also, compared with parallel computing using
threads, Asyncio adopted a radically different solution for race conditions. Code
written with Asyncio is less error-prone: by just looking at the code, it is possible to
identify which parts of the code are under our controls and where the event loop takes
over the control flow and can run other tasks when our task is waiting for something.
Figure 3.5: The ETL engine. The event loop schedules the asynchronous tasks
from the plan based on the dependency graph. While some tasks are waiting for IO
intensive operations, the event loop takes over the control flow and is able to run
other tasks.
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As shown in Fig. 3.5, the ETL engine maintains an event loop and a multi-
processor pool to execute a DAG of tasks, called a plan. When the engine starts, or
every time a task is completed, it enqueues all ready tasks, i.e., the pending tasks
without any incomplete depending task. A task is defined as a coroutine with inputs
including the engine’s context (containing the database pool and engine log), and the
outputs from its depending tasks. Then once it is completed, its output will be the
Figure 3.6: An example ETL task to query the database.
part of the inputs of its dependent tasks. Fig. 3.6 shows a simple code example of a
database query task. Note that while this task is waiting for executing the database
query, the event loop can operate other concurrent tasks.
Therefore, an ETL pipeline can be represented as a plan and use the ETL engine to
execute the plan in parallel. The plan, specifically, defines feature mapping process as
a group of tasks and use the semaphore to control the maximum number of concurrent
tasks. For fill-in and derive processes, since they are implemented as SQL queries,
we partition the queries by enc id so that each task can be executed as multiple
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concurrent DB queries orthogonally. To avoid any possible conflicts or deadlocks since
fill-in and derive functions operate on the same table, we configure the event loop to
allow only one such task a time, i.e., semaphore = 1. Alternatively, another option
is to adopt the column-wise parallelism, i.e., executing fill-in function column by
column and then executing multiple derive functions simultaneously. However, since
The PostgreSQL database (and most of the SQL databases) are row-oriented and use
multi-version concurrency control (MVCC), column-wise parallelism can cause two
problems: 1) changing one item in a row means to create a whole row with a new
version so update one column in a table means the whole table needs to be recreated;
2) bulk inserting or updating different columns but the same rows from multiple
processes may cause conflicts and even deadlocks, which may not be scalable or even
be the opposite. The parallel performance is evaluated in Section 3.5.
It is also worth mentioning that this ETL engine framework is used on both
offline dataset ETL in DW and online data pipeline. The only difference between the
online and offline ETL pipelines is that since the online pipeline extracts EHR from
web services, the feature mapping functions are specifically implemented to run web
requests instead of database queries. But the rest of the tasks, e.g., fill-in and derive
functions, are reusable.
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3.5 Evaluation
To understand the performance of “read” and “write” on CDM datasets, this
section evaluates the scalability of the ETL engine in performing the three major
ETL processes: feature mapping, fill-in, and derive. Two parallel approaches, row-
wise and column-wise parallelism, are evaluated in the CDM data warehouse using the
JHMI CDM datasets. In the end, this section also evaluates the query performance
of the CDM datasets.
3.5.1 Experiment setup
In this evaluation, both the DW and ETL machines used the AWS m4.2xlarge
instances which have 8 vCPUs, 32 GB memory, and 1,000 Mbps maximum bandwidth.
We used the historical EHRs stored in the Clarity database from JHMI to evaluate
the ETL performance. Specifically, we dumped the clinical related EHRs from the
three main hospitals in JHMI (as shown in Table 3.2) to the DW and measured the
performance of converting them to CDM. The features used in this evaluation are list
in Table 3.3 which are the key features we used to develop TREWS. The sizes of the
CDM datasets are list in Table 3.4.
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Inpatient visits 223K 574K 141K
Flowsheet Rows 3795 MB 6060 MB 1766 MB
Lab results 551 MB 7672 MB 1107 MB
MAR 491 MB 2894 MB 809 MB
Procedure Orders 699 MB 3996 MB 989 MB
Notes 8550 MB 5576 MB 5059 MB
Table 3.2: Historical EHR extracted from the Clarity database of JHMI. HCGH,
JHH, and BMC are the three main hospitals of JHMI.
Category Count Examples
ADT 1 Arrival time
Demographics 5 Age, gender, admission time
Diagnoses 30 Dx of septic shock, sepsis, pancreatic cancer, etc.
Flowsheet 18 Weight, heart rate, fluid intake, etc.
LDAs 1 Catheter
Labs 29 WBC, lactate, sodium, etc
Medical History 31 Hx of septic shock, sepsis, pancreatic cancer, etc.
MAR 140 Amoxicillin, Penicillin, Propofol, etc.
Notes 10 sepsis, UTI, pneumonia sepsis notes, and so on
Order Procedures 12 BiPAP, CPAP, EKG procedure, etc
Problem List 34 The problem list including septic shock, sepsis, etc.
Derivative features 45 SIRS, SOFA, severe sepsis, septic shock, etc.
Table 3.3: CDM features used in the evaluation.
Dataset HCGH JHH BMC
Number of enc ids 223,945 574,506 141,884
Number of rows in cdm s 1,352,121 2,914,305 726,114
Number of rows in cdm t 29,095,535 48,783,459 13,920,056
Number of rows in cdm df 4,439,429 6,462,794 2,098,752
Number of rows in cdm note 3,346,552 1,113,181 1,063,274
Table 3.4: The sizes of the CDM datasets in DW.
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3.5.2 Feature mapping
We first evaluated the process of feature mapping, which includes extracting all the
measured features (i.e., except derivative features) from EHR staging tables in DW,
and then transforming and loading to the cdm s, cdm t, and cdm note tables. We de-
fined each feature mapping task as an ETL task in the ETL engine and measured the
speed-up of the throughputs (i.e., number of enc id per second) while increasing the
number of semaphores and processors of the ETL engine. The number of semaphores
controlled the maximum number of concurrent tasks executed in the ETL engine,
and the number of processors specified the maximum number of CPUs used in the
processor pool.
(a) One process (b) Two processes
Figure 3.7: The performance of parallel feature mapping
The performance is illustrated in Fig. 3.7. We set the number of processes from
one to two and the semaphore from 1 to 64, i.e., the number of concurrent tasks in
the event loop. For example, that semaphore is equal to 1 means all feature mapping
tasks have to execute sequentially. The y-axis in the figure shows the throughputs
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(enc id per second) of different settings. First, notice that doubling the number
of processes used in the ETL engine did not improve the performance for this IO
intensive process, i.e., one CPU core was sufficient to handle all computations in the
ETL instance. Then, we can see that the throughput scaled from 20 enc id/s with one
semaphore to 100 enc id/s with 32 semaphores. The throughput converged at eight
semaphores because it uses all the cores in the DW instance to run the extraction and
loading. The throughput slightly increased from 8 to 32 due to the various amount of
loading size among features, i.e., having more concurrent tasks can keep the database
always busy. However, once the semaphore increases to 64, the performance dropped
due to the increased overhead of context switches.
3.5.3 Fill-in process
Secondly, we evaluated the fill-in process using two parallel approaches: row-wise
vs. column-wise. As mentioned in Section 3.4, the fill-in process is fully implemented
as SQL queries on the single cdm df table. We hypothesize that row-wise parallelism
allows all workers run orthogonally to maximize the speed-up using multi-cores; in-
stead, even though theoretically the column-wise approach can partition the features
independently, in practice, the fundamental data structure used in Postgres database
tables may mainly reduce the gain from the parallelism.
Fig. 3.8 shows that row-wise fill-in function scaled from 100 enc id/s to nearly 350
enc id/s while increasing the number of DB workers from 1 to 8. Instead, the column-
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wise fill-in function did not speed up with the increasing number of DB processes.
Even when the number of DB processes is one, row-wise parallel is faster than column-
wise parallel because the former only needed to traverse and update each row once
while the latter needed to traverse and recreate each row N times, here N is the
number of columns.
(a) Row-wise (b) Column-wise
Figure 3.8: The performance of parallel fill-in function: row-wise vs. column-wise
3.5.4 Derive process
Thirdly, similar to fill-in function, the two parallel approaches – Patient-wise and
function-wise – were evaluated here. To execute the DAG of derivative features, the
patient-wise approach partitioned the cdm df table into groups of patients and de-
rived features one by one; alternatively, the function-wise derive multiple independent
features simultaneously. We hypothesize that the patient-wise approach can paral-
lel orthogonally, but the function-wise can slow down due to the conflicts or even
deadlocks while accessing the same rows in the same Postgres table from different
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processes.
Fig. 3.9 shows the patient-wise derive process could scale from 13 enc id/s to
56 enc id/s, which was over four times improvement. While instead of scaling up,
the throughput of the function-wise approach slightly dropped from 13 enc id/s to
7 enc id/s, i.e., less than half of the throughput, which was due to the conflicts and
deadlocks occurred among concurrent derive functions.
Figure 3.9: The performance of parallel derive process: patient-wise vs. function-
wise
Based on the throughput benchmark of the above three steps, creating one of the
largest CDM dataset, i.e., JHH, only requires around 5 hours. Compared with the
non-parallel approach which needs around 22 hours, it can save 77% of the ETL time.
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3.5.5 CDM queries
Besides the performance of writing data into CDM data warehouse, we also eval-
uated the reading performance, i.e., CDM queries, using a single processor. We
attempt to show the duration for reading data from an entire CDM dataset and the





SELECT * FROM pat enc WHERE dataset id = x 3.0 191.5K
SELECT * FROM cdm s WHERE dataset id = x 24.5 23,4K
SELECT * FROM cdm t WHERE dataset id = x 2,066.3 278.0
SELECT * FROM cdm df WHERE dataset id = x 1,618.2 355.0
SELECT * FROM cdm note WHERE dataset id = x 132.2 4345.7
SELECT * FROM calculate historical criteria(pat id) 8.1 N/A
Table 3.5: The mean execution time and throughput of example SQL queries on
the JHH dataset (using only one DB worker)
Table 3.5 shows the performance of some typical queries using one DB processor or
connection. For example, the average execution time to extract all rows from the JHH
data frame is 1,618.2 seconds (less than half an hour) or 191.5K enc id/s. The last
query example — calculate historical criteria() — calculate the CMS sepsis
criteria at every hour during the time of hospitalization for one patient. It requires 8
seconds in average to generate one patient’s hourly report using one DB worker. We
will discuss the solution to further improve those queries in Section 3.6.
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3.6 Discussion
CDS-Stack introduced a simple and homogenous data model — CDM — as the
data layer of ML core functionalities. It can dramatically reduce the high complexity
of clinical data and the ETL engine could accelerate the development of both offline
and online data pipelines for new ML-based CDS. In addition, to extend an ML-based
CDS to new hospitals or institutes, most of the ETL pipeline can be reused, and the
developers only need to adjust the site-dependent part, i.e., feature mappings.
The CDM design and implementation have several limitations. First, the current
data storage is implemented and evaluated on a single database which is limited by
the total number of CPU cores and the maximum IO bandwidth. This will be a
bottleneck for both write and read especially for DW when more and larger datasets
have been created.
Second, the current CDM feature definition follows an ad-hoc or application-
specific fashion. This can be a drawback when one CDM feature definition is going
to support multiple applications. Creating and maintain a standard clinical feature
dictionary can be beneficial for extending the CDM features to broader usage. We
started the first step by open sourcing the CDM features we created for sepsis early
detection.
Overall, one of the future directions to improve CDM is to implement it in a
distributed and column-orient database. Since the CDM schema is highly scalable
on the enc id, the dataset can be partitioned in multiple database machines and
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CDM queries can be run concurrently without space and bandwidth constraints. In
addition, a column-orient database should contribute to the derive functions, i.e.,
each derive function can only update one particular column without affecting other
columns, which is impossible to do in a row-orient database. AWS Redshift34 and





“I am aware that success is more than a good idea. It is timing too.”
– Anita Roddick
4.1 Introduction
Once a machine learning model is developed and evaluated in the CDM data
warehouse, the last mile of the end-to-end CDSS is to set up a production system
to deliver the CDS to the treatment team. Four major steps can be involved in this
stage, shown in Fig. 4.1:
• ETL: The ETL engine runs the pipeline of web requests, transform functions,
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Figure 4.1: Major steps to deliver online diagnostic decision support.
and loading functions to convert EHR to CDM database.
• Predict: the system requests the online machine learning service (predictor) to
make predictions based on the latest patient data.
• Update: the system updates all data models needed to show to the users, e.g.,
prediction results, related clinical criteria and explanation.
• Present: the system presents the updated CDS back to the EHR vendor in form
of web pages and notification messages.
How to trigger and run this pipeline in a live mode? If we consider the CDSS
as a client-server system between the CDS-Stack and the EHR vendor, then the pull
and push are the two types of protocols to communicate between this client-server
system. In pull protocols, the client (i.e., the CDS-Stack) periodically connects to the
server (i.e., the EHR vendor), checks for and gets (pulls) recent EHR data and then
run the rest of the pipeline. In this mode, the client repeats this whole procedure to
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get updated about new EHR data. In push protocols, the client opens a connection
to the server and keeps it constantly active. The server will send (push) all new
events to the client using that single always-on connection. The difference is that in
push protocols, you get new events instantly (such as a new patient admission, a new
lab result, etc.). But you may experience a time delay in pull protocols depends on
the interval between two online pipelines. We elaborate the implementations of pull
and push-based online data pipeline in Section 4.2 and evaluate their performance in
Section 4.3.
4.2 Implementation of the Pull- and Push-
based Pipelines
The CDS-Stack includes both pull-based and push-based data pipelines to enable
real-time online clinical decision support.
The pull-based online data pipeline, as shown in Fig. 4.2, is triggered periodi-
cally by a timer with a certain time interval, 15 minutes by default. The timer is
implemented as an AWS Cloudwatch event, and it periodically fires an AWS Lambda
function which initializes an ETL job at one of the computing instances in the pro-
duction auto-scaling group. The ETL job runs an ETL engine to extract EHR from
the REST API of the EHR vendor 1, transform EHR to CDM, and load it to the
1We choose the REST API because it is the most well-maintained and used interface in JHMI’s
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Figure 4.2: The implementation of the pull-based online pipeline, which is triggered
by a periodical timer event from AWS CloudWatch.
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Figure 4.3: The implementation of the push-based online pipeline. It maintains
always-on connections to receive EHR events instantly and trigger ETL mini-batchs
to calculate real-time CDS.
database. After the ETL job is completed, an “ETL Done” message, which includes
the enc ids updated in this ETL job, is sent to the alert server. The alert server is
an internal web service to coordinates the components in the online CDSS. Once it
receives the “ETL Done” message, it forwards the message and distributes the predic-
tion tasks to a series of connected predictors. The predictors will send a “Prediction
Done” message back to the alert server after they make the predictions. Then, the
alert server updates all CDS-related data models, e.g., criteria and alerts, and notify
the web services with a “Invalidate Cache” message. Finally, the web services refresh
their caches, update all the ongoing web sessions, and push alerts to the EHR vendor.
EHR system
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In contrast, the push-based online data pipeline, as shown in Fig. 4.3, is triggered
based on the events generated from the targeted EHR system. In this implementation,
a group of scalable components — EventProxy — maintain the connections with the
EHR vendor’s event dispenser and forward new events to a buffer in the AWS Simple
Queue Service (SQS). The SQS provides a queue which offers maximum through-
put, best-effort ordering, and at-least-once delivery. Using the SQS guarantees all
events can be buffered during an event burst. Another set of scalable components
— EventServer — keep dequeuing the SQS buffer and run an ETL engine to exe-
cute such a mini-batch ETL job. Then, the rest of the pipeline is the same as the
pull-based one.
The ETL mini-batch is implemented into two tasks. First, it dequeues all events
from SQS every 15 seconds, and then parse the events to a list of web requests to run.
The transformed results are saved as a CDM buffer; Second, it runs a loading task
every 30 seconds to save all data from current CDM buffer to the online database.
These two types of tasks are triggered by the timers independently and adaptively.
Taking the loading task as an example, it starts to run every 30 seconds when the
CDM buffer is not empty and the previous loading task has completed. Since the
ETL engine uses Asyncio instead of multi-threading, we don’t need to worry about
race condition which makes the implementation much easier. Note that the mini-
batch still needs to run web requests because the event payload does not contain the
values updated in the EHR system, e.g., an “add flowsheet” event (e.g., add a new
62
CHAPTER 4. DELIVERING REAL-TIME CLINICAL DECISION SUPPORT
heart rate) only contains the patient ID and the flowsheet ID but does not contain
the value (i.e., heart rate and the timestamp).
In sum, the major benefits of using the push-based protocol, instead of pull-based
one, are two-fold: First, the online pipeline can start to calculate new CDS instantly
once the new events have been captured by the EventServer; while the pull-based
one needs to wait for the trigger from the next timer event. Second, the push-based
pipeline knows which patients have events generated and can only update on these
patients, so it will be much more efficient because the amount of the latest updated
patients should be much smaller than the number of all the bedded patients.
4.3 Evaluation
We evaluate the implementations of the pull and push-based protocols in our
JHMI deployment in this section. The evaluation attempts to compare the cost and
performance of the two protocols. Specifically, we evaluate the overhead of the online
ETL on the targeted EHR system, e.g., the rate of online EHR requests, and the
performance of the online service, e.g., the latency of the end-to-end ETL pipeline,
for each protocol.
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4.3.1 Experiment setup
We setup two separate pipelines with the different ETL protocols to compare the
performance of the pull and push-based ETL pipelines, the infrastructure is list in
Table 4.1. Also, the online EHR data source is served as REST APIs by the JHMI
Component Usage Instance vCPU Memory (GiB) Replicas
Database pull&push db.m4.xlarge 4 16 1
AlertServer pull&push t2.medium 0.25 2 1
Predictor pull&push c4.large 2 3.75 1
ETLJob pull m4.large 0.25 1 3
EventProxy push r4.large 0.1 0.25 4
EventServer push r4.large 0.1 0.25 4
Table 4.1: The infrastructure used in the pull and push-based pipelines.
web service team. On one side, the three pull-based ETL jobs periodically request
recent EHRs for bedded patients every 15 minutes, from the three hospitals, JHH,
HCGH, and BMC, respectively.
On the other side, the four EventProxy instances guarantee that all incoming
events can be pushed to the AWS SQS queue instantly. And the four ETL instances,
i.e., EventServer, keep dequeuing all pending events 2 from the SQS buffer as a
mini-batch with a minimum interval of 30 seconds. The four replicas can guarantee
the SQS buffer never queue up in current experiment so that we can assume once the
event is enqueue, it can be dequeue to a mini-batch immediately.
2The events included all five hospitals in JHMI since the event dispatcher pushed events from all
hospitals in JHMI and no hospital filter exist so far
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4.3.2 The online EHR request rates
Figure 4.4: The number of EHR API requests per pull-based ETL over one week.
The online EHR request rate quantifies the major overhead of the online ETL as-
sociated with the targeted EHR system. Fig. 4.4 shows the number of API requests
per pull-based ETL over one week. Taking JHH as an example, the number of bed-
ded patients stabilized around one thousand. The two major types of requests were
requests of flowsheet rows and medication administration. The number of requests
for flowsheet rows in each pull-based ETL was floating between 20 to 30 thousand
and reached to the peak during daytime in weekdays. Overall, the pull-based ETL
needed more than 20 requests per second as shown in Fig. 4.5a.
In contrast, the push-based ETL was triggered by the online EHR events. Fig. 4.6
shows the total number of events received over one month. Those events included
both inpatient and outpatient events within all five hospitals in JHMI. The amount
of events followed a weekly pattern, i.e., high volume in weekdays and low volume in
weekends. It also followed a daily pattern in weekdays which indicated the hospitals
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(a) Pull-based ETL (b) Push-based ETL
Figure 4.5: The rate of EHR web requests: pull vs. push
stayed in the peak time from 8 AM to 6 PM. Also, the peak time only occurred in
weekdays.
(a) Events per hour over one month
(b) Events per hour for weekdays (c) Events per hour for weekends
Figure 4.6: The total number of events received from JHMI EHR
The statistics of the data events can be found in Fig. 4.7 and Fig. 4.8. Over 80%
of data events were flowsheet related. Also, we can see that most of the medications
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(a) Flowsheet added events per hour for
weekdays
(b) Flowsheet add events per hour for
weekends
(c) Order signed events per hour for
weekdays
(d) Order signed events per hour for
weekends
(e) Lab result updated events per hour
for weekdays
(f) Lab result updated events per hour
for weekends
Figure 4.7: The key data events received from JHMI EHR (Part 1). Over 80% of
data events are flowsheet row related.
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(a) MAR given events per hour for week-
days
(b) MAR given events per hour for week-
ends
(c) Note updated events per hour for
weekdays
(d) Note updated events per hour for
weekends
Figure 4.8: The key data events received from JHMI EHR (Part 2).
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(a) Admit events per hour for weekdays (b) Admit events per hour for weekends
(c) Transfer events per hour for weekdays
(d) Transfer events per hour for week-
ends
(e) Discharge events per hour for week-
days
(f) Discharge events per hour for week-
ends
Figure 4.9: The ADT events received from the JHMI EHR.
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were given from 8 AM to 9 AM and from 8 PM to 9 PM.
The ADT (admit, discharge, transfer) events are shown in Fig. 4.9. The peak of
patient admission happened in the morning of weekdays, while, the peak of patient
discharge happened around 6 PM. Some spikes in the figures, e.g., admission at
midnight and transfer at 3pm were system generated events.
The push-based ETL consumed those EHR events and parsed them into web
requests for current inpatients only. The rate of web requests by the push-based ETL
was around 10 and 7 requests per second at the peak time (i.e., daytime in weekdays)
and at the rest of the time respectively, as shown in Fig. 4.5b, which is less than half
of the usage in the pull-based ETL.
4.3.3 The end-to-end latencies: pull vs. push
Another key benefit of using push-based protocol is the reduction of the end-
to-end latency compared with the pull-based approach. We evaluate the end-to-end
latencies of the pull and push-based online data pipelines here. The end-to-end latency
measures the duration from the beginning of one ETL job to the completion of the
TREWS prediction (short for P) and criteria calculations (short for C). Note that in
our pilot study, only inpatients from HCGH has been predicted by TREWS, other
patients bypassed the online prediction step.
Fig. 4.10 shows the latencies of the three hospitals using the pull-based ETL.
The maximum latency was near 900 seconds for JHH (1,091 beds in total), i.e., it
70
CHAPTER 4. DELIVERING REAL-TIME CLINICAL DECISION SUPPORT
(a) HCGH (267 total beds) (b) JHH (1,091 total beds) (c) BMC (493 total beds)
Figure 4.10: The end-to-end latencies of the pull-based online data pipelines for
the biggest three hospitals in JHMI. The average throughput of the full pull-based
pipeline (HCGH) was 0.7 beds/s.
took near 15 minutes to extract EHR, transform to CDM, and then present them as
CMS criteria in the web services. The ETL of HCGH needed near 480 seconds, i.e.,
8 minutes, to complete the full pipeline including TREWS online prediction. The
average throughput of the full pull-based pipeline was 0.7 beds/s.
Instead, Fig. 4.11 shows the end-to-end latencies using push-based ETL on three
different time ranges, which are daytime in weekdays (peak time), nighttime in week-
days, and weekends. It is obvious the highest latency happened at the daytime in
weekdays but all end-to-end latencies are within 90 seconds. The ET, L, P, and C
shows the individual durations in each step respectively. ETLPC shows the end-to-
end latency for HCGH patients who run full end-to-end pipeline including TREWS
online prediction, while ETLC shows the end-to-end latency excluding online pre-
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(a) Daytime in weekdays (b) Nighttime in weekdays (c) Weekends
Figure 4.11: The push-based end-to-end latencies (2,399 total beds). The average
throughput of the end-to-end push-based pipeline (including prediction) was 80.0
beds/s.
diction for patients in JHH and BMC. Notice that the latency of ETLPC is higher
than the sum of all individual components because it includes the gap between the
two tasks in the ETL mini-batch, i.e., 1) parse and pull EHRs from the API and 2)
transform EHRs into CDM. These two tasks ran independently and the results from
the first task stored in a buffer for the second task to consume. The gap showed the
interval when the first task was done but the second task was not ready to process
the new results, i.e., the second task was running for the previous results. In sum,
the average throughput of the end-to-end push-based pipeline was 80.0 beds/s.
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4.4 Discussion
The CDS-Stack introduced both pull and push-based pipelines to deliver online
clinical decision support. Especially for the push-based one, its maximum end-to-end
latency is within 90 seconds, 10 times less than the latency using the pull-based one
and the average throughput can achieve 80 beds/s, more than 100 times faster than
the push-based one; furthermore, it only needs less than half of the requests to the
API compared to the pull-based one. To our best knowledge, it is the first time to
enable push-based online data pipeline in ML-based CDSS.
As the first step towards online ML-based CDS, it still has several limitations.
One of the major limitations of the push-based data pipeline is that it is still not a
complete push-based protocol because it still needs to request the REST APIs (i.e.,
pull data related to the latest events). In a complete push-based protocol, the event
payload should include the updated data so that the ETL does not need to request
the REST APIs again. An option to implement it is to use HL7 and FHIR protocols
because it pushes the complete EHRs to the client, so the client does not need to pull
again. The challenge is that HL7 and FHIR may not be available in some medical
centers and customized EHRs may not deliverable in these protocols.
Another limitation is that the evaluation only focuses on the end-to-end perfor-
mance inside CDS-Stack, specifically the ETL pipelines. A complete end-to-end per-
formance evaluation should include the targeted EHR system as well. For example, to
measure the latency from when an EHR item is typed in the system to when the CDS
73
CHAPTER 4. DELIVERING REAL-TIME CLINICAL DECISION SUPPORT
is displayed to the treatment team. Such a complete end-to-end performance can give
a picture of the entire closed loop. In sum, CDS-Stack provides a complete solution
to serve both historical and online EHRs in CDM format for machine learning usage.
We believe this solution can be used not just for inpatients or hospital settings, but
also for outpatients or other third-party applications as well. For example, health
data collected outside of the hospital can be transformed into CDS-Stack if a proper
API is provided. For example, daily motion data, heart rate collected by wearable
devices, can be imported from their APIs36,37 to CDS-Stack by implementing the
feature mapping for them. And the CDS-Stack, especially the CDM format and the
pull and push-based pipelines, is general and simple to develop and apply machine
learning-based CDS using its cloud infrastructure.
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Chapter 5
The Mobile Parkinson Disease
Score: Using Smartphones and
Machine Learning to Quantify
Parkinson Disease Severity
“We need to bring the exam room to where the patients are.”
– Dr. Jay Sanders, telemedicine pioneer
In this chapter, our research moves from inpatient clinical decision support to
outpatients, specifically patients living with Parkinson disease (PD). This chapter
demonstrates how machine learning and smartphone sensing can be integrated to
reform the monitoring and management of long-term illness like PD on a daily basis.
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Current Parkinson disease measures are subjective, rater-dependent, and require
in-clinic assessment.38,39 As a result, clinical trials using these measures are long,
expensive, and can miss or generate false signals.39,40 Many PD motor symptoms
are well-suited to objective measurement by smartphones.41–43 Smartphone assess-
ment has been evaluated in PD, but most studies focus on one specific feature (e.g.
gait), rather than overall symptom burden.43,44 We developed an Android smart-
phone application (“HopkinsPD”) that assesses five activities (voice, finger tapping,
gait, balance, reaction time) (See Appendix A),45 which can be completed as often
as desired, and enables reporting of medication administration. We create a mobile
Parkinson Disease score (mPDS) to serve as an objective measure of PD, and test
construct validity by evaluating 1) the ability of the mPDS to detect intraday symp-
tom fluctuations; 2) the correlation between the mPDS and standard measures; and
3) the ability of the mPDS to respond to dopaminergic therapy.
5.1 Methods
5.1.1 Study population
Individuals with PD and Android smartphones were invited to download Hop-
kinsPD through the Parkinson’s Voice Initiative;46 participants provided electronic
consent for data analysis with application download. Data from participants who
completed at least one complete set of activities before and after their first daily dose
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of dopaminergic medication were used to develop the mPDS (development cohort).
We also recruited and obtained written consent from individuals with and without
PD to complete smartphone activities alongside traditional assessments, including the
Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS),
Hoehn & Yahr, and Timed Up and Go at baseline, month 3, and month 6 (clinic co-
hort). All study procedures were approved by the University of Rochester Research
Subjects Review Board.
5.1.2 Creating the mPDS
Data from the development cohort were processed to extract novel disease features
from each of the five activities (e.g. inter-tap interval from the finger tapping activity;
See Appendix A).45 Rather than replicating an existing PD score using regression,
we used a rank-based machine-learning algorithm—disease severity score learning
(DSSL)47— to derive an independent measure of PD symptom severity: the mPDS,
which is scaled from 0-100 with high numbers reflecting high symptom severity. To
weigh unique features, the algorithm exploits weak supervision48 based on the assump-
tion that symptom severity is higher at one time, immediately preceding dopaminer-
gic medication administration, compared to another, one hour following medication
administration. Given many such pairs, DSSL estimates a score by optimizing an
objective function to correctly rank as many pairs as possible. Further description of
the method can be found in Appendix B. Code for feature extraction and the DSSL
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learning algorithm was open sourced at https://github.com/dashan-emr/mpds.
5.1.3 Ability of mPDS to detect intraday fluctua-
tions
We evaluated the ability of the mPDS to capture symptom variability by eval-
uating the average intraday range in mPDS among home-performed assessments in
those with PD in the clinic cohort.
5.1.4 Comparison of mPDS to traditional measures
Smartphone and traditional assessments completed within two hours of each other
were used to compare the mPDS to traditional measures in individuals with PD.
Pearson’s correlation was calculated between the mPDS and the MDS-UPDRS III
and total, Timed Up and Go, and Hoehn and Yahr.
5.1.5 Responsiveness of mPDS to dopaminergic ther-
apy
We evaluated the ability of the mPDS to respond to dopaminergic therapy in the
clinic cohort by comparing the mPDS derived during optional clinic-performed off-
vs on-medication evaluations. A one-tailed Wilcoxon signed-rank test was used to
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assess significance (α = 0.05).
5.2 Results
250 individuals with PD downloaded HopkinsPD; 129 fulfilled requirements for
the development cohort. 23 individuals with PD and 17 without PD constituted
the clinic cohort. Baseline characteristics are shown in Table 5.1. Those with PD
completed 58 in-clinic assessments (22 at baseline, 18 at month 3, 18 at month 6);
those without PD completed 37 assessments (17 at baseline, 8 at month 3, 12 at
month 6).
5.2.1 Creating the mPDS
During 6 months, development cohort participants performed a mean (SD) of 48
(61) complete activity sets (range 2-278). 435 unique features were extracted from
the five smartphone tasks. Eight features from the finger tapping activity, three from
the balance activity, three from the gait activity, and one from the voice activity
contributed most toward mPDS generation (Supplement). The relative weighting of
features in generating the mPDS was gait (33.4%), balance (23.2%), finger tapping
(23.0%), voice (17.0%), and reaction time (3.4%). The average mPDS (over all as-
sessments) was 47% lower in controls (30.3, SD 15.0) than in those with PD (57.5,
SD 16.9).
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n = 250 n = 129 n = 23 n = 17
Demographics
Age (years) 57.2 (9.4) 58.7 (8.6) 64.6 (11.5) 54.2 (16.5)
Sex (% women) 95 (38.0%) 55 (42.6%) 11 (48%) 12 (71%)








238 (95.2%) 121 (93.7%) 14 (61%) 8 (47%)
Using the inter-
net or email at
home (%)




4.4 (4.9) 4.3 (4.4) 7.0 (4.1) N/A
Proportion tak-
ing levodopa (%)




N/A N/A 55.0 (26.5) 4.6 (4.6)
MDS-UPDRS
III score




N/A N/A 11.2 (3.3) 8.1 (1.3)
Hoehn & Yahr N/A N/A 2.1 (0.7) 0.0 (0.0)
We list mean (standard deviation) pairs except where indicated
MDS-UPDRS = Movement Disorder Society —Unified Parkinson”s Dis-
ease Rating Scale
Table 5.1: Baseline characteristics.
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5.2.2 Ability of mPDS to detect intraday fluctua-
tions
During 6 months, clinic cohort participants performed a mean (SD) of 210 (323)
complete activity sets (range 2-996). The mPDS detected an average intraday change
of 13.9 (SD 10.3) among those with PD. Fig. 5.1a depicts intraday severity fluctua-
tions. The average MDS-UPDRS IV score was 4.6 (SD 4.3).
(a) Intraday severity fluctuations captured for one participant
(b) Assessment frequency of mPDS vs. Movement Disorder Society-Unified Parkinson”s
Disease Rating Scale Part III over six months
Figure 5.1: Mobile Parkinson disease score (mPDS) assessment scores captured over
6 months
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5.2.3 Comparison of mPDS to traditional measures
Sixteen smartphone and traditional assessment pairs met criteria for analysis.
Table 5.2 shows the correlation matrix between the mPDS and traditional measures,
demonstrating good to excellent correlation. Fig. 5.1b demonstrates the ability of the
mPDS to monitor symptom severity more frequently than traditional measures.
Table 5.2: Correlation matrix between the mobile Parkinson disease score (mPDS)
























0.72 0.74 0.27 1.00
Hoehn &
Yahr Stage
0.91 0.96 0.80 0.70 1.00
a mobile Parkinson disease score b Movement Disorder Society-Unified Parkinson”s Disease Rating Scale
5.2.4 Responsiveness of mPDS to dopaminergic ther-
apy
Seven off- and on-medication assessment pairs were performed in the clinic cohort.
The mPDS decreased by an average of 16.3 (SD 5.6) in response to dopaminergic
therapy with significant Wilcoxon signed-rank test (W=28, p=0.008). The MDS-
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UPDRS III decreased by an average of 10.4 (SD 4.6) in response to dopaminergic
therapy.
5.3 Discussion
The mPDS is a novel measure that provides rapid, remote, frequent, and ob-
jective assessment of PD symptom severity on widely available smartphones. We
demonstrated construct validity by showing that the mPDS can: 1) capture intraday
fluctuations characteristic of PD; 2) correlate with traditional PD measures; and 3)
respond to dopaminergic medication.
The mPDS is complementary to traditional PD measures. First, assessments can
be performed frequently in real-world settings.49 Second, the score provides an ob-
jective measure of PD symptom severity, not impacted by inter-rater variability.50
Third, the mPDS, unlike traditional measures, objectively weighs activity features.
The MDS-UPDRS III is biased toward tremor-predominant disease1 with only five of
33 items assessing gait or balance. In contrast, 56.6% of the mPDS is derived from
gait or balance activities. Last, unlike traditional measures, which take years and
significant resources to develop,1 the mPDS was generated quickly, from a relatively
small number of participants using automated techniques that can account for noise in
data collected from multiple smartphone sensors and self-report of medication admin-
istration.51 Combining smartphone data with the machine-learning methods outlined
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here may also provide opportunities for developing objective severity measures in
other neurological conditions.
This study has several limitations. Participants were generally white, college-
educated, Android smartphone owners, and not representative of the broader PD
population. Only 52% of those who downloaded the application met criteria for in-
clusion in the development cohort. Additionally, the clinic cohort included only seven
assessments to evaluate the responsiveness of the mPDS to dopaminergic therapy, and
only 16 smartphone and in-person assessment pairs met criteria for the correlation
analysis. Still, this represents one of the largest longitudinal smartphone assessment
of PD.
Further validation of the mPDS in a larger sample with patient-relevant anchors
is needed. New iterations of the application for Android and iOS smartphones will
expand participation and include additional features and functionality that could




“To learn without thinking is blindness; to think without learning is idle-
ness.”
– Confucius, The Analects of Confucius
This dissertation research stands on the shoulder of prior work in a number of
ways. This chapter describes previous work, how it has inspired this dissertation, and
the contributions that this dissertation offers beyond existing research. Section 6.1
discusses the current infrastructure which enables machine learning in both academy
and industry. Section 6.2 focuses on the deployment and practice of using machine
learning in clinical decision support. Section 6.3 discusses the current open EHR data
models. Section 6.4 discusses state of the art in using machine learning and mobile
technologies to track Parkinson disease in the wild.
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6.1 Infrastructure for Machine Learning
Practice
6.1.1 Motivation
Machine learning is being deployed in a growing number of applications. Over
the past five years, voice-driven personal assistants have become commonplace, image
recognition systems have reached human quality, and autonomous vehicles are rapidly
becoming a reality.52 A series of open-source machine learning frameworks are avail-
able now to accelerate the core development of machine learning, i.e., training and
prediction. Those frameworks includes Scikit-learn,17 Apache Spark MLLib,18 Ten-
sorFlow,19 Caffe,53 and Torch,54 etc. However, those frameworks mainly contribute
to model training or evaluation but not deployment and maintenance. In practice,
the core of machine learning — training or prediction — is a comparatively small,
albeit critical, part of the overall application lifecycle.
Sculley et al.13,55,56 sought to increase the community’s awareness of the severe
technical debt that must be considered and paid in practice over the long term for ma-
chine learning systems. They explored several ML-specific risk factors to account for
in system design. These included boundary erosion, entanglement, hidden feedback
loops, undeclared consumers, data dependencies, configuration issues, changes in the
external world, and a variety of system-level anti-patterns. They hoped to encourage
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additional development in the areas of maintainable ML, including better abstrac-
tions, testing methodologies, and design patterns. They argued both engineers and
researchers should be aware of this issue since research solutions that provide a small
accuracy benefit at the cost of massive increases in system complexity are rarely wise
practice. Even the addition of one or two seemingly innocuous data dependencies can
slow further progress.
Lin et al.14 also shared the Twitter experience in scaling big data mining infras-
tructure. The most prominent lesson they learned was that successful big data mining
was about much more than what most academics would consider data mining. A sig-
nificant amount of tooling and infrastructure was required to operationalize vague
strategic directives into concrete, solvable problems with clearly-defined metrics of
success. The infrastructure and system design should help data scientists (who spent
a significant amount of effort performing exploratory data analysis even to figure out
“what’s there”, including data cleaning and data munging not directly related to the
problem at hand) and data infrastructure engineers (who worked to make sure that
productionized workflows operate smoothly, efficiently, and robustly, reporting errors
and alerting responsible parties as necessary).
6.1.2 Practices
Since building machine learning applications remains prohibitively time-consuming
and expensive for all but the best-trained, best-funded engineering organizations, the
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Stanford DAWN project52 aimed to provide a stack of systems and tools to support
usable, end-to-end machine learning applications. The ultimate and ambitious goal
of this on-going project was to democratizing machine learning technology and let
one or two domain experts can build their production-quality data products (without
requiring a team of PhDs in machine learning, big data, or distributed systems, and
without understanding the latest hardware). DAWN attempted to achieve their goal
from three directions: One, to develop new interfaces from model specification to
model monitoring to empower domain experts who are not ML experts. For exam-
ple, they have obtained promising early results with a new system called Snorkel57
that produces high-quality models from low-quality rules. Also, Rong et al.58 utilized
automatic smoothing to improve streaming time series visualization and human at-
tention. Two, to design end-to-end systems that encapsulate the whole ML workflow
and hide internals from users, similar to a search engine or a SQL database. One
example was MacroBase,59 an analytics engine and architecture for analyzing fast
data streams, which combined streaming outlier detection and streaming data ex-
planation. Three, to develop new computational substrates, from language support
to distributed runtimes and accelerated hardware, so that training and deploying
ML can be quick and in a cost-effective manner. For instance, they were developing
Weld,60 a new runtime that can optimize data-intensive code across different libraries
and functions to automatically generate fast implementations either for ML training
or serving. Weld can already accelerate modern data analysis tools such as Apache
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Spark, Pandas and TensorFlow by 10 times by optimizing across the operators within
them, and can accelerate cross-library workloads by up to 30 times.
Clipper61 was a general-purpose low-latency prediction serving system interpos-
ing between the end-user applications and a wide range of machine learning frame-
works. It introduced caching, batching, and adaptive model selection techniques to
reduce prediction latency and improves prediction throughput, accuracy, and robust-
ness without modifying the underlying machine learning frameworks.
Other example of industry machine learning production system is Michelangelo62
made by Uber. Uber faced several challenges of building and deploying machine
learning models related to the size and scale of their operations. For example, those
challenges included the tool separation between data scientists and engineering team,
i.e., a ML model developed by data scientists needed to reimplement again to fit pro-
duction environment by the engineering team; and no system in place to build reliable,
uniform, and reproducible pipelines for creating and managing training and predic-
tion data at scale. Michelangelo was designed to address these gaps by standardizing
the workflows and tools across teams though an end-to-end system that enables users
across the company to easily build and operate machine learning systems at scale.
6.1.3 Discussion
From our experience in developing CDS-Stack and deploying it into real healthcare
practice, we faced the similar system and infrastructure challenges aforementioned
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in above relate work. Especially, Sculley et al.13 and Lin et al.14 described and
summarized the problems we were facing.
In our study, the first question we had was how to quickly and efficiently establish
an end-to-end machine learning system on the cloud? Was there a software we can use
to deploy and maintain the end-to-end CDSS and iterate the machine learning model?
Unfortunately, there was no such an open-source software available. Even though
the research articles aforementioned in Section 6.1.2 provides a series of promising
systems and algorithms in this domain, they commonly abstracted a particular or
partial functionality from a real end-to-end system and improved it with novel ideas.
So it is impractical to apply those ideas without a baseline system has been set up.
These are the leading reasons we built and open sourced CDS-Stack and share
with the peers who also aim to reform healthcare using machine learning. CDS-Stack
can be used to establish a testbed or infrastructure for developers to experiment
actionable end-to-end ML-based CDS and keep improving it from different aspects.
For example, the idea of automatic smoothing58 can be adopted in CDS-Stack and
can be compared with baseline visualization; Also MacroBase59 can be integrated to
setup streaming outlier detection and streaming data explanation. One of the future
work for CDS-Stack is to improve its modularity as a testbed to plug and play these
new ideas, not just new machine learning models.
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6.2 Clinical Decision Support System and
Machine Learning
6.2.1 Clinical decision support system from a prac-
tical view
Despite promising initial studies from the academia, the majority of CDSS in
practice have not provided features beyond general alerts, reminders, summary dash-
boards, and automated information retrieval systems.63 A majority of United States
hospitals have yet to implement any form of CDSS.64,65 “Comprehensive” EHR sys-
tems are those that include decision support features (clinical guidelines, clinical
reminders, drug-allergy alerts, drug-drug interaction alerts, drug laboratory interac-
tion alerts, drug-dosing support); only 1.5% of 2952 hospitals surveyed achieved a
“comprehensive” classification.66
Taking JHMI as an example, clinical decision support is embedded within Epic
EHR system in a variety of formats. Specifically, the Epic Decision Support work-
group is primarily responsible for configuring alert-based decision support interven-
tions including medication alerts, Best Practice Advisories (BPAs), and health main-
tenance. Even in a top medical institute like JHMI, only less than 20 clinical decision
BPAs have been deployed and most of them are simple and rule-based screening
tools and guidelines, e.g., BMI screening and follow-up plan,67 diabetes nephropathy
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Screening,68 and Pneumonia Vaccination.69
Overall, few studies of CDSS have shown any improvement in outcomes, and any
such effects seen have achieved only low statistical significance.64 A meta-analysis of
148 randomized clinical trials on CDSS implementation found that only 20% influ-
enced clinical outcomes.65 Of these, improvements were seen in morbidity outcomes
such as number of hospitalizations, surgical site infections, cardiovascular events, and
deep vein thrombosis, but there was little effect on mortality or pharmacologic ad-
verse events,65 suggesting that CDSS will need improvement before they can routinely
provide clinically meaningful knowledge.
6.2.2 Diagnostic machine learning algorithms us-
ing EHRs
Applying machine learning into clinical decision support becomes a hot topic and
wildly believed is that it will improve the quality of care and even surpass human
experts. Recently, more and more retrospective analysis studies show machine learn-
ing can be a useful tool in disease diagnosis, especially for some complex diseases,70
clinical events, and procedures, e.g., sepsis,7–9,71,72 heart failure,73 cancer,10 asthma,
Parkinson disease,11,41,45,74 medical images like chest X-ray,75,76 etc. In those stud-
ies, historical EHRs have been extracted, labeled, and evaluated by specific machine
learning algorithms with metrics like the area under the curve (AUC), positive pre-
92
CHAPTER 6. RELATED WORK
dictive value (PPV), sensitivity and specificity, detection hours before onset, etc.
6.2.3 Systems designed for ML-based CDS
However, the systems for the deployment of online machine learning-based CDS
are relatively rare. We discuss state of the art on the practices of ML-based CDS
below.
Ng et al.77 developed the PARAMO system, a predictive modeling platform which
constructed a large number of pipelines in parallel with MapReduce/Hadoop. How-
ever, PARAMO was built on the user’s own cluster, which was not always available
in every clinical institution, and also lack scalability when faced with large datasets
beyond the capacity of their existing cluster. Also, most pipelines such as PARAMO
were challenging to deploy in a clinical setting due to the significant expenses re-
quired to maintain servers. Therefore, these systems made little to no impact on
clinical decision-making.
To help address the limitations of PARAMO, Chen et al.70 developed and deployed
a hybrid system that combined a secure private server with the cloud-based Amazon
Web Services (AWS) Elastic MapReduce platform. The system consisted of a web
service that ran on a private server in a secure environment for preprocessing patient
data into feature matrices, and an on-demand AWS web service to perform predictive
modeling computations. Such a hybrid setup attempt to enable security of the patient
data and at the same time leveraged the scalable computing infrastructure on the
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cloud.
6.2.4 Discussion
The CDS-Stack is different from above two systems in the following sense: First,
CDS-Stack is open and reusable, while the above two systems were not available
outside of the lab. Second, CDS-Stack is a pure cloud-based system. It is more
scalable and manageable than the private cluster, e.g., PARAMO. Third, CDS-Stack
provides HIPAA secure and compliant implementation, so the hybrid design in 70 is
not necessary. A secure and cloud-based system can directly integrate with the EHR
vendor which does not need to set up a private cluster as a gateway. Last, CDS-Stack
also includes the database layer and live end-to-end pipeline to deliver CDS and the
above two systems still mainly focused on offline training.
6.3 EHR Data Models
6.3.1 Current EHR data models
Taking the industry leader, Epic, as an example, the current EHR is relative
closed for the purpose of developing machine learning-based CDS. First, the database
schema and data are closed, developers need to get trained and certified so that they
can access the data schema and the data. There is no open document or playground
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for developers to start learning. Second, the Epic system was implemented based on
versions of the antiquated but powerful programming language (MUMPS). Therefore,
there is no machine learning library and experts can directly work on the antiquated
platform and build machine learning applications. Third, the interoperability is lim-
ited due to the Epic’s software distribution model: it customizes its EHR software
for each client which limits the interoperability between sites and the capacity to
communicate with providers who use other EHRs. While there is potential for EHRs
with functional data linkages to be used for research purposes, currently the lack of
interoperability between EHRs hinders research capabilities.78
6.3.2 Open EHR data models
Currently, enabling the broader usage of EHRs can be done in two ways: restricted
assess and altered data. The integrating Biology and Bedside (i2b2) project79 allows
researchers to query for aggregate summaries of the data without access to individual
level information. Similar to CDS-Stack, i2b2 also provides a simple data schema
that allows very diverse patient data from the enterprise to be integrated into a few
central tables that simplify the search and analyze on the data that the enterprise
makes available on its patients. Besides, another notable success in the release of
data in critical care is the PhysioBank component of PhysioNet, and in particular
the Multiparameter Intelligent Monitoring in Intensive Care II and III (MIMIC-II,
MIMIC-III) database.29,80 The data has been provided to researchers after certifi-
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cation of completion of a human subjects training course and the signing of a data
use agreement. The database is a great step toward removing barriers between re-
searchers and real-world data necessary to validate their work. Both i2b2 and MIMIC
databases de-identified PHI (patient health information) and provides anonymous pa-
tient data, the purpose is to share the data to external researchers. The two above
architectures focus on EHR analysis and does not provide any support on applying
the analytical results back to the EHR system.
6.3.3 Discussion
Therefore, instead of aiming at EHR data sharing, the goal of CDS-Stack is to
provide this open source tool to help researchers or developers build their own ML-
based CDSS. CDS-Stack provides a pipeline constructor to turn EHR into data frame
so that researchers can focus on ML relevant development. Whiling using the CDS-
Stack, researchers/developers can reuse the database schema and most of the ETL
pipeline in both the development and production stage. However, ML models trained
on i2b2 or MIMIC-II need to create the online data pipeline from scratch.
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6.4 Machine Learning and Remote Mon-
itoring for Parkinson Disease
Remote monitoring of Parkinson disease is needed to improve the quantity and
quality of care for PD. Currently, individuals living with PD have access to care or
participate in research primarily during in-person clinic or research visits, which take
place at most once every few months. More frequent clinic visits are limited by travel
distance, increasing disability, and uneven distribution of doctors.81 Without remote
monitoring, it is difficult for clinicians to provide optimal treatment for their patients
based on these periodic “snapshots” of the disease progression alone.82
6.4.1 The readiness of sensing technology for Parkin-
son remote monitoring
Existing studies have required the use of specialized and expensive medical devices
such as accelerometers, gyroscopes, EEG and passive infrared sensors.83–89 Many of
these studies have also only reported data collected in the laboratory setting,83–85,88,89
which does not faithfully represent the patterns of variability that individuals with
PD may experience at home. Also, the majority of past studies have focused on
monitoring only one aspect of PD such as dyskinesia,85 gait,86,88,90–92 voice,93 postural
sway,90 and resting tremor.89,94 However, PD is a multi-faceted disease with many
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varied symptoms. Thus, a multi-dimensional approach is needed to monitor all PD
symptoms at home continuously.
6.4.2 Using smartphone and machine learning in
remote monitoring of Parkinson disease
Smartphone-based tracking and measurement tools offer a promising new avenue
for monitoring progressive symptoms outside the clinic. Moreover, without the need
for expensive specialized medical hardware, new software tools can be easily down-
loaded and installed on an individual’s smartphone for in-home monitoring. For
example, Apple’s ResearchKit95 enabled several clinical studies to collect patients’
data from smartphones remotely. The targeted population of those clinical studies
included patients with Parkinson disease,96 Asthma,97 gait problems,98 melanoma
risk,99 cognitive problems,100 etc.
With the increasing data size and complexity, machine learning provides a solution
for researchers/physicians to analyze the collected data and turn it into meaningful
clinical related decision support. Taking Parkinson disease as an example, Several
studies introduced machine learning to diagnose Parkinson disease, i.e., distinguish
Parkinson patients from healthy controls.41,45,90 And other studies focus on particular
symptoms, e.g., tremor,101,102 gait.103 Those studies suggested a promising direction
to use smartphone and machine learning to quantify the symptoms of Parkinson
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disease.
6.4.3 Discussion
Most of the aforementioned PD studies using machine learning and smartphones
still did the experiments in a lab setting on a relatively small number of participants.
Instead, our study adopted a pure remote and at-home setting, similar to the studies
using Apple’s ResearchKit, and the number of participants exceeded other contem-
poraneous studies. Such a large and remote study also addressed a new crucial prob-
lem, i.e., how to get labels (i.e., Parkinson severity) for those remote participants?
Without clinically validated labels, it is impossible to use supervised learning, the
dominant machine learning approach in existing studies. Therefore, our study intro-
duced a weak learning method and utilized the symptom changes before and after
medication to learn a severity model for Parkinson. Meanwhile, our study provided
a physician-understandable score, mPDS, which is similar to standard Parkinson as-
sessment scores, to quantify severity. Also, mPDS is a unified score measuring multi-
dimensional symptoms including voice, gait, balance, and dexterity, and provided a
high-frequent and overall answer to the daily Parkinson severity variance which used
to be hidden to physicians.
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Conclusion and Future Work
This dissertation has reported the journey we took to bring machine learning-based
clinical decision support into clinical practices. During this journey, we have explored
how to build cloud-based infrastructure to support the development, deployment, and
maintenance of machine learning-based CDS from scratch. We have contributed the
core of our implementation — CDS-Stack — the open-sourced platform to accelerate
the process of building end-to-end ML-based clinical decision support systems for all
ML practitioners in healthcare. On top of this platform, we have designed CDM, a
common data model, to represent EHRs in a specific and straightforward format for
ML usage. We also have implemented an ETL engine for transforming raw EHRs
into CDM in parallel. Both pull-based and push-based data pipelines have been
provided to enable live CDS delivery back to the EHR system. Using CDS-Stack, we
have deployed a sepsis early warning alerts — TREWS — into JHMI hospitals and
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support tens of thousands of inpatients since 2017. We believe CDS-Stack could be
an invaluable tool to fill the gaps between machine learning and healthcare practice
and catalyze the practice of using machine learning in healthcare.
This dissertation has also shown the benefits of extending ML-based CDS from
in-hospital settings to daily health monitoring and management. An example ap-
plication mPDS has been proposed to quantify Parkinson severity using smartphone
and machine learning. It has demonstrated that the power of ML-based CDS is not
just assisting diagnosis, but also generating new meaningful information in disease
management.
Still, the contributions of this dissertation present the first step towards realizing
machine learning-based clinical decision support. More work needs to be done to
build a robust, extensible, and clinician-friendly clinical decision support ecosystem.
This dissertation attempts to list several promising future directions as follow.
First, the dramatical explosion of health data streams is still on-going, includ-
ing EHRs recorded the hospitals and other health-related, personal, physiological,
psychological, and social data generated from mobile, wearable, and any other net-
worked devices. Therefore, human attention-based or manual data exploration and
data quality control seem increasingly impossible to satisfy the future clinical decision
support system. We have to rely on automation to meet the challenge of this live,
heterogeneous, and big data volume. Integration of automation system and outlier
detection algorithms can be a potential solution for this purpose. One challenge is
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how to build such a detector with high sensitivity and specificity to detect not just
outliers but also distinguish errors with clinically meaningful information.
Second, CDS-Stack is available but need to further extend to other EHR systems
and practices. We hope CDS-Stack can be an open testbed tool for other researchers
to establish more machine learning-based clinical decision support system. New ap-
plications, machine learning models, and system ideas or tools can be evaluated on
such a modular and scalable system.
Last but not least, with the catalyst of CDS-Stack, more practical applications,
like mPDS, should be developed and evolved in healthcare practice. In summary,
this dissertation hopes can share our experiences to flatten bumps in the road for
those practitioners who come after us. Also, for academic researchers, it attempts
to provide a broader context for machine learning-based clinical decision support in
production-level and point out opportunities for future work.
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A HopkinsPD Android Application
HopkinsPD is an open source Android application to collect smartphone activities
related to Parkinson disease, as shown in Fig. A.1 and Fig. A.2. HopkinsPD server
provides basic web-based visualization tool for researchers, see Fig. A.3. As a research
platform, HopkinsPD has enabled multiple research projects since it was deployed
in 2014. 11,41,45,74,90,104–109 The source code of HopkinsPD is available at https:
//github.com/zad/HopkinsPD_Android.
Table A.1 list all implemented smartphone activities related to Parkinson disease.
Table A.2 provides an exhaustive list of the features extracted from the five types
of activities, along with a brief description of each feature. Acceleration features
were based on definitions used in previous studies.74112113 Acceleration features were
computed from the tri-axial acceleration time series (x, y, and z-axis), as well as the
spherical transformation of the tri-axial acceleration time series (i.e., radial distance,
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Figure A.1: HopkinsPD architecture.
(a) Primary interface (b) Self-report
(c) Active tests
Figure A.2: HopkinsPD mobile application.
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(a) Timeline: user monitoring
(b) An example of test view: voice view
(c) Part of the day view
Figure A.3: HopkinsPD web-based visualization.
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Voice Place the phone to your ear
as if making a normal phone
call, take a deep breath, and
say “aaah” for as long and as
steadily as you can.




Balance Stand up straight unaided











Gait Stand up and place the
phone in your pocket. When
the buzzer vibrates




walk forward for 20 yards;






Dexterity Place the phone on a surface








alternately with the index







Reaction Keep the phone on a surface
as before. Press and hold the
on-screen button (i.e., at the
bottom of the screen) as
soon as it appears; release it












Sit upright, hold the phone
in the hand most affected by
your tremor, and rest it












Sit upright and hold the
phone in the hand most
affected by your tremor











* Activities have been implemented but not used in mPDS.
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Table A.2: Brief description of features extracted for active tests
Feature Brief Description
Acceleration mean: Mean
Featuresa std : Standard deviation
Q1 : 25th percentile
Q3 : 75th percentile
IQR: Inter-quartile range (IQR) (Q3 −Q1)
median: Median
mode: Mode (the most frequent value)
range: Data range (max - min)
skew : Skewness
kurt : Kurtosis
MSE : Mean squared energy
En: Entropy
MCR: Mean cross rate
DFC : Dominant frequency component
AMP : Amplitude of DFC
meanTKEO : Instantaneous changes in energy due to body motionb
AR1 : Autoregression coefficient at time lag 1
DFA: Detrended fluctuation analysis110
XCORR: Cross-correlation between two axes
MI : Mutural information between two axes
xEn: Cross-entropy between two axes
Voice Len: Voice duration in seconds
Features AMP : Voice amplitude
F0 : Dominant voice frequency
AMP and F0 features include mean, standard deviation, DFA, and the coeffi-
cients of polynomial curve fitting with degree one and two respectively
Dexterity apply the same feature set (includes mean, standard deviation, Q1, Q3, IQR,
median, mode, range, skew, kurt, MSE, En, meanTKEO, AR1, DFA) on two
groups of tapping intervals:
Features STAY : length of time finger stays touching the phone screen
MOVE : time interval between release of touch to the next touch event
Reaction apply the same feature set on the lags of finger reactions (i.e. the time intervals
Features between the stimulus appearing and the finger touch event), including sum,
mean, standard deviation, Q1, Q3, IQR, median, mode, range, skew, kurt,
MSE, En, meanTKEO, DFA
a Acceleration features are used for both balance and gait tests
b TKEO stands for Teager-Kaiser energy operator111
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polar angle, and azimuth angle). We apply the acceleration features in Table A.2 for
these six axes respectively. As the acceleration time series were sampled at irregular
time intervals, we applied the Lomb-Scargle periodogram to extract frequency-based
features,114 e.g., the dominant frequency component in Hz and its amplitude. All
the acceleration features are used by both the balance and gait tests. To extract
the voice features, we first divide the 20-second audio sample into 40 frames leading
to 0.5 second frame duration. Then, we tag each frame as containing a “voiced”
signal if that frame has amplitude greater than the first quartile of the amplitudes
among all frames. Then, for further analysis, we select the longest consecutive run
of voiced frames. The length of the largest consecutive run of voiced frames is the
“voice duration” feature. Other features extracted from these voiced frames include
dominant frequency and amplitude (see Table A.2). Dexterity features are extracted
from the stay duration, that is, the length of time the finger stays touching the screen,
and the move duration which is the interval of time between a finger release and the
next finger press. The reaction features focus on the lag times of finger reactions (i.e.
the time intervals between the stimulus appearing and the finger touch event). The
feature extraction library is available at https://github.com/dashan-emr/mpds.
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Figure B.1: Linear disease severity score objective.
B Disease Severity Score Learning
One general kind of approach for creating a severity score algorithm is based on
supervised learning: here, experts evaluate the participants at multiple time points
to provide the clinical, “gold-standard” score at each time point (e.g., MDS-UPDRS
score). Based on these evaluations, a regression function is estimated that maps
features (algorithms such as sensor data variability, complexity and summarized fre-
quency information) derived from the smartphone sensor data collected during the
smartphone activities into a continuous or discrete-valued score. The key challenge
of using such an approach is that it relies heavily on obtaining a large number of
gold-standard clinical evaluations, which are very expensive and time-consuming to
collect.
Instead, we used a rank-based machine learning algorithm—disease severity score
learning (DSSL)47—to create the mobile Parkinson disease score (mPDS). In order to
estimate a score from feature data, DSSL uses weak supervision48 where the resulting
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labels may have an associated error rate. For example, to estimate mPDS parameters,
DSSL exploits example pairs of times that are rank ordered in severity such that the
severity of symptoms at time ti is less than that at time tj. Using the data collected in
this study, such example pairs were easily obtained: for an individual responding to
medication, the severity of symptoms at a time right before medication administration
is assumed to be higher than that an hour after taking their medications.
Given many such pairs, DSSL estimates a score by optimizing the objective shown
in Fig. B.1. Here, x represents a feature vector derived from the sensor data recorded
during activities collected using HopkinsPD at a given time. A total of 435 features
were computed from the five smartphone-enabled test activities. For example, we
computed 126 features from the gait and balance tests each to capture changes in
body motion, including the mean, median, standard deviation, range, entropy, and
dominant frequency from the tri-axial acceleration time-series. 151 features were
computed from the tapping test screen touch events, to quantify attributes such
as finger tapping speed (e.g., total number of taps within a given period of time),
precision of tapping (e.g., range of tap positions normalized by smartphone screen
size), and rhythm and inter-tap interval. Detailed descriptions of the features were
previously published elsewhere.45 Each i, j is a numerical index associated with two
distinct timestamps, at times ti and tj, at which activities were conducted. Each p, q
represents two distinct patient indices. The vector w is a vector of weights estimated
by DSSL. To compute the mPDS on a new patient at a given time t given a recording
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of their activities at that time and the resulting feature vector x computed from the
sensor data collected during these activities, the linear projections w ·x are computed.
These linear projections are raw and unscaled. To ease interpretability in a clinical
setting, the mPDS is scaled between 0 and 100, where values close to 0 reflect low
severity while those close to 100 reflect high severity.
The set O is the set of all available pairs of tuples (< xpi , t
p





that are ordered by severity; from the development cohort, such pairs are computed
automatically based on the activities performed at times right before medication
administration and those from the hour after. Severity is assumed to be lower post
medication administration. In the second term in Fig. B.1, Lh is the Huber loss
function. This second term in the objective encourages DSSL to estimate a score
that satisfies the severity ordering prescribed by the tuples in set O. We had a total
of 3074 such pairs available in the development cohort.
The set S, denoted by pairs of tuples (< xpi , t
p




i+1 >), are obtained
based on tests taken at consecutive times within a few hours of each other but without
medication administration during the interim period. The third term in Fig. B.1
encourages temporal smoothness for the pairs specified in set S. The coefficients O
and S are DSSL regularization parameters and control the relative degree of emphasis
on the smoothness between consecutive pairs in the third term of the objective versus
maximizing the difference in severity for pairs specified in the second term. These
were set using 10-fold cross-validation on the development cohort.
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[48] J. Hernández-González, I. Inza, and J. A. Lozano, “Weak supervision and other
119
BIBLIOGRAPHY
non-standard classification problems: a taxonomy,” Pattern Recognition Let-
ters, vol. 69, pp. 49–55, 2016.
[49] M. R. Lemke, T. Wendorff, B. Mieth, K. Buhl, and M. Linnemann, “Spa-
tiotemporal gait patterns during over ground locomotion in major depression
compared with healthy controls,” Journal of psychiatric research, vol. 34, no. 4,
pp. 277–283, 2000.
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